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ABSTRACT
DESIGN AND APPLICATION OF PHOTOACTIVATABLE OLIGONUCLEOTIDES
Brittani K. Ruble
Ivan J. Dmochowski
Photoactivatable oligonucleotides are DNA or RNA molecules whose function is
temporarily blocked or “caged” by a chemical moiety that can be activated by light. By
using light to turn on activity, high spatial and temporal control of oligonucleotide
function can be attained. We have developed novel techniques to cage oligonucleotides
using light-activatable groups that introduce a strand break upon photolysis. One method
of inhibiting gene expression involves the use of catalytic DNA strands known as
DNAzymes, specifically ones with the ability to cleave RNA. We have demonstrated
efficient photomodulation of a biotinylated split DNAzyme by employing streptavidin to
disrupt the active conformation. Light-controlled split DNAzymes could potentially be a
tool for studying gene expression in vitro. Additionally, a novel photochemical approach
for isolating mRNA from single neurons was developed by creating hairpin-bandage
hybrids. This design utilizes a photoactivatable oligonucleotide hairpin that targets the
poly(A)+ tails of mRNA.

The antisense strand of the hairpin is linked via a

photocleavable spacer to the blocking strand, which is divided into two parts by a second
photocleavable spacer. Experiments in single neurons have confirmed the utility of
hairpin-bandage hybrids for fluorescently monitoring oligonucleotide dissociation in vivo
and for isolating of mRNA from single cells.
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Chapter 1
Introduction to light-activatable oligonucleotides
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I. Overview of caged compounds
A “caged” compound can be defined as one whose activity is temporarily blocked
by a chemical moiety until it undergoes photolysis. Caged compounds have a chemical
group that is covalently attached and rapidly cleaved upon irradiation with light. The
most famous caged compound is light-activatable ATP, in which the gamma phosphate is
caged with a 2-nitrobenzyl group or 1-(2-nitro)phenylethyl group. In the caged state,
ATP cannot be hydrolyzed by ATP-dependent proteins. After near-UV irradiation at 340
nm, the nitrobenzyl group photoisomerizes, causing a bond break with the gamma
phosphate and restoring ATP function (Figure 1.1)[1].
The use of caged compounds can allow reactions to be spatially localized, for
instance, to single cells, and the time of initiation can also be controlled. In one example,
caged ATP was used to study reaction kinetics of contraction and relaxation in muscle
fibers[2]. This study highlights the key advantages of light-activatable groups, namely
providing higher spatial and temporal resolution for studying complex biological systems
than many traditional methods. To date, several small molecules have been caged for use
in biological studies; these include Ca2+, fluorophores, neurotransmitters, and other
nucleotide triphosphates.

Caging groups have also been utilized in a vast array of

biological studies, such as those examining cell motility and other cellular processes [3].
II. Examples of caging groups
The three most commonly used caging groups are nitrobenzyl, coumarin, and
azobenzene (Figure 1.2). Since near-UV light is less invasive and orthogonal to most
biological processes, it is important to find groups that can be uncaged at longer
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wavelengths. Nitrobenzyl groups used in caged ATP studies absorb at wavelengths
below 350 nm, but modifications have been made to improve its uncaging efficiency at
longer wavelengths. An improved nitrobenzyl derivative that absorbs at wavelengths
greater than 350 nm is the 1-(4,5-dimethoxy-2-nitrophenyl)ethyl compound.
The coumarin caging group is another highly used moiety.

Brominated 7-

hydroxycoumarin-4-ylmethyl esters and carbamates have been used to make two-photon
caged compounds that have led to the first three-dimensionally resolved maps of neuron
glutamate sensitivity in intact mouse brain slices[4].

For two-photon uncaging, a

compound absorbs a pair of photons at IR wavelengths almost simultaneously, as
opposed to the one UV photon required for other caging moieties.

The longer

wavelengths required are less affected by scattering, less damaging to cells and biological
samples, and can penetrate tissue more deeply[5]. However, there are disadvantages to
two-photon uncaging. First, it requires pulsed lasers that can be tuned to the wavelengths
required.

Additionally, this technique is more synthetically challenging, and the

chemistry involved in synthesizing these compounds is not as well-developed.
For reversibly controlling function, azobenzene groups have been utilized[6]. At
visible wavelengths, azobenzene is in the extended trans conformation, but after UV
irradiation, it adopts the cis conformation.

While the utility of early azobenzene

derivatives suffered because azobenzene cis  trans isomerizes rapidly at 37 °C,
requiring continuous UV irradiation to maintain the cis conformation, variants with
improved thermal stability have been developed recently[7].
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More recently, caging techniques have been expanded to develop light-activated
oligonucleotides for spatiotemporally regulating gene expression to elucidate complex
biological processes. By using photolabile moieties that transiently block DNA or RNA
function, it is possible to control the activity of oligonucleotides in a variety of
applications.

For instance, controlling when or where proteins are expressed will

facilitate the study of how they affect cellular development. Furthermore, the ability to
isolate total mRNA populations from a single cell at a given point in time will aid in
elucidating the link between RNA and cell phenotype.
III. Photoactivatable oligonucleotides
Caging techniques have greatly expanded over the last twenty years going from
small molecules to biologically relevant compounds, such as oligonucleotides and
proteins.

However, caging oligonucleotides is often more challenging than small

molecules due to their larger size and complexity. There are currently a few methods to
incorporate caging groups. First, if the oligonucleotide is short, the photoactivatable
group can be made into a phosphoramidite and incorporated during solid-phase synthesis.
Phosphoramidites, in which a base has been modified with a photocleavable group (such
as diethylaminocoumarin) at a position on a nucleoside ring[8], have been synthesized, as
have linkers that can be added between the bases (resulting in strand breaks postphotolysis)[9]. Photoactivatable groups can also be incorporated after oligonucleotide
synthesis. Bifunctional linkers that are reactive with nucleophiles, such as thiols or
amines, have been successfully added after solid-phase synthesis[10]. Photocleavable
groups that are reactive to the phosphate backbone of the oligonucleotide have also been
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utilized[11].

Examples of this type include diazoethane derivatives of coumarin and

nitrobenzyl groups and 1-(4,5-dimethoxy-2-nitrophenyl)ethyl.
Even though the term “caging” can be a bit of a misnomer in the case of
oligonucleotides because caging groups can be incorporated to turn oligonucleotide
function “off” or “on” post-photolysis, the term “caged” continues to be used because
their function is controlled by light. Photoactivatable oligonucleotides have several
applications, which will be discussed in the sections below.

These include caging

plasmids and messenger RNA to block transcription or translation, caging atoms required
for the catalytic activity of nucleic acid enzymes, photomodulating antisense
oligonucleotides to control oligonucleotide binding to complementary sequences,
photoregulating oligonucleotides for other uses, and indirectly regulating oligonucleotide
activity by caging small molecules and cofactors.
a. Caged plasmids and messenger RNA
The

first

example

of

a

caged

plasmid

used

1-(4,5-dimethoxy-2-

nitrophenyl)diazoethane groups to react with oxygens of the phosphate backbone in a
GFP plasmid[12]. In this study there were ~270 caging groups per plasmid, and this
suppressed most transcription of the DNA in HeLa cells. Unfortunately, the bioactivity
of the plasmid was not fully restored after uncaging with 365 nm light. This was likely
due to the large number of caging groups present, which required a high dose of light for
photo-deprotection, but this led to cell death. Additionally, there was some background
GFP expression because the caging reaction is random, resulting in different plasmid
structures, with some having no caging groups and others having a large number of them.
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In

another

example,

Ando

et

al.

utilized

6-bromo-4-diazomethyl-7-

hydroxycoumarin moieties, which form a covalent bond with the phosphate backbone of
RNA and label ~30 sites per 1 kb of DNA or RNA[13]. Here, a GFP plasmid was caged,
as was GFP messenger RNA. The zebrafish was utilized as a model system because of
its transparency, and after transfection with the GFP plasmid, irradiation with UV light
resulted in GFP expression, with expression levels increasing with longer irradiation
times. They expanded work with this caging group to investigate the role of the lhx2
gene in zebrafish[14]. While lhx2 is known to be involved in brain and eye development,
its function had previously been difficult to study because zebrafish embryos would
become extremely dorsalized with enlarged heads when the gene was overexpressed
using traditional methods. This is because overexpression occurs in the whole embryo
early in development. By caging lhx2 mRNA, they successfully overexpressed Lhx2
only in the head at a specific time in development. By controlling overexpression of
lhx2, the authors were able to rescue knockdown of another gene, six3, in the head region
at 11 hours post-fertilization.

This study is a prime example of how useful caged

oligonucleotides are for studying problems in developmental biology.
Since the presence of multiple caging groups requires more irradiation to uncage
than would be necessary for a single caging moiety, more recent strategies have aimed to
incorporate only one or two caging groups. Recently, a plasmid with only a single caging
group was developed[15]. In this design, a DNA primer with a 5′-amine modification was
synthesized and incorporated into a GFP plasmid a few bases upstream of the
cytomegalovirus (CMV) promoter via PCR.

After reacting the amine with a

photocleavable biotin, streptavidin was added to sterically block the promoter region of
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the plasmid, thus blocking transcription factors from binding. The caging moiety used
for this study is the 6-bromo-7-hydroxycoumarin-4-ylmethyl group.

In cell studies,

enhanced GFP (EGFP) expression increased from 65% of normal levels (i.e. that of noncaged plasmid) prior to irradiation up to 92% after irradiation.
b. Light-regulatable catalytic oligonucleotides
DNAzymes and ribozymes are nucleic acids that are capable of catalyzing
chemical reactions. While some ribozymes, such as the hammerhead ribozyme, occur
naturally, all known DNAzymes have been evolved by in vitro selection. The first
example of photoregulating a nucleic acid enzyme incorporated a caged adenosine within
an RNA cleaving ribozyme[16]. An adenosine with a caged 2′ hydroxyl was synthesized
as a phosphoramidite to allow it to be incorporated during solid-phase synthesis. The 2′nitrobenzyl cage at this position blocked the ribozyme’s function because the 2′ hydroxyl
is required for magnesium dependent nucleophilic attack on the phosphodiester linkage in
RNA.
Since the first caged ribozyme, other caged nucleic acid enzymes have been
developed. Strategies for caging DNAzymes have included blocking their function by
caging their bases because the catalytic mechanisms of DNAzymes are not fully
understood. Two of the most studied DNAzymes are the 8-17 DNAzyme and the 10-23
DNAzyme, both of which have been caged by site-specifically incorporating
photoactivatable bases at important positions within the enzyme using phosphoramidite
chemistry[17]. In both of these studies, DNAzyme function was blocked until uncaging
with UV irradiation resulted in RNA degradation, which turned gene expression “off.” In
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the case of the 8-17 DNAzyme, an adenosine analogue was incorporated at a position in
the stem loop that is required for activity[17a]. The caged DNAzyme was completely
inactive, but after irradiation, ~30% of activity was restored. Lusic et al. developed a
thymidine phosphoramidite caged with the 6-nitropiperonyloxymethyl (NPOM) group to
introduce into the catalytic core of a 10-23 DNAzyme[17b].

They discovered that

disrupting a single hydrogen bond could completely block enzymatic activity if
strategically placed, and irradiation with 365 nm light could activate the enzyme with
greater than 50% of the original activity restored. More recently, the Deiters lab has
successfully photoregulated DNAzyme function is mammalian cells[18]. Incorporating
three caged bases into a DNA decoy strand that is complementary to the catalytic loop of
the DNAzyme prevented the decoy strand from binding the DNAzyme until after
irradiation with UV light. After irradiation, the trans acting decoy strand hybridizes to
the DNAzyme, which prevents RNA digestion.

They also demonstrated that the

complementary strand could be added before the 5′ binding arm of the DNAzyme rather
than as a separate strand.
Additionally, reversible 8-17 and 10-23 DNAzymes with azobenzene have been
developed. This approach can be challenging because the oligonucleotide must function
normally when the azobenzene is in one conformation, but its function must be blocked
when the azobenzene is in the other conformation. However, the ability of azobenzene to
photoisomerize reversibly can be advantageous in some instances since light-activation of
other caging groups irreversibly removes the photoactivatable moiety. Because of this,
reversibly photoregulatable DNAzymes have been developed by replacing important
bases with a nucleotide that is modified with an azobenzene group[19]. Interestingly, the
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8-17 DNAzyme displayed higher catalytic activity with azobenzene in the trans form, but
the 10-23 DNAzyme was more active with the azobenzene in the cis conformation.
When two azobenzene groups were substituted for nucleotides in the binding arms of an
8-17 DNAzyme, the catalytic rate of the enzyme was approximately five times higher in
the trans conformation than in the cis form[19a]. This is a result of the increased stability
of the enzyme-substrate complex due to the ability of trans-azobenzene to stack within
the DNA double helix, thereby stabilizing it. In the case of the 10-23 DNAzyme, a single
nonconserved nucleotide within the catalytic core of the enzyme was replaced with a 2′deoxyuridylate analogue linked to an azobenzene moiety[19b].

When the enzyme-

azobenzene conjugate is in trans form, the activity is decreased by nine-fold compared to
the wild-type enzyme.

After UV irradiation, when the azobenzene is in the cis

conformation, the enzyme’s cleavage rate approaches that of the unmodified DNAzyme.
More recently, a photoregulatable 10-23 DNAzyme nanomachine was created by
adding complementary hairpin sequences incorporating three or four azobenzenes on
either side of the DNAzyme’s binding arms[20]. Since the azobenzenes are in the trans
conformation in visible light, a stable duplex hairpin-like structure forms, and the
DNAzyme cannot cleave RNA.

However, in UV light, the azobenzenes isomerize,

causing the duplex to dissociate. The enzyme is then able to bind and digest its RNA
target.

Photoregulation of this DNA nanomachine was highly efficient, allowing

digestion to be turned completely off after UV irradiaton.
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c. Caged antisense oligonucleotides
A more recent, widely used caging approach aims to control the activity of
antisense oligonucleotides.

These are short oligonucleotides comprised of 15-25

nucleotides that hybridize to an mRNA transcript to cause it to be degraded or prevent
translation by sterically blocking the ribosome. For example, when a short DNA strand
hybridizes to its target mRNA in cells, RNase H is recruited and degrades the mRNA.
Modified oligonucleotides, such as RNA with 2′ modifications, morpholinos, peptide
nucleic acids, and phosphorothioate DNA, can bind to an mRNA of interest to prevent
translation by blocking the ribosome. The technique most commonly used for antisense
caging is to block it transiently from hybridizing to its target mRNA.
As discussed previously with caged plasmids, hybridization of antisense
oligonucleotides to target mRNA can be prevented by caging the phosphate backbone.
Ghosn et al. randomly caged the phosphate backbone oxygens of a 20mer DNA using 1(4,5-dimethoxy-2-nitrophenyl)ethane[21]. The resulting oligonucleotide was labeled at an
average of 14-16 sites, and this was sufficient increase disruption of hybridization to a
complementary molecular beacon from 14% of non-caged control to 80% after
irradiation with UV light. To achieve more specific backbone labeling, an iodoacetamide
derivative of azobenzene has been utilized to cage phosphorothioate DNA[22]. In this
example, one base per 16mer was caged, and this resulted in a 7 °C decrease in melting
temperature post-photolysis.
Photoactivatable modifications within the nucleotides of caged antisense
oligonucleotides can also be used to control activity. For example, incorporation of three

11

nitrophenyl-modified thymidine phosphoramidites in a 25-nucleotide DNA strand
resulted in significant decrease in melting temperature after photocleavage, lowering it by
21.5 °C[23]. Azobenzene modifications have also been created as phosphoramidites. By
incorporating three of these moieties in a 22-nucleotide DNA strand, a three-fold increase
in RNase H digestion of the target RNA was achieved after UV irradiation[24]. More
recently, the Deiters group utilized thymidine phosphoramidites in the synthesis of
phosphorothioate DNA[25]. In this study, incorporation of three or four caged residues
per 18mer oligonucleotide led to successful gene regulation in cell culture. This group
also developed light-activatable morpholino oligonucleotides for controlling EGFP
expression in cell culture and in live zebrafish embryos[26]. In this study, four morpholino
monomers caged with the 6-nitropiperonyloxymethyl (NPOM) group were included in a
25mer sequence.

This design was successful in silencing EGFP expression post-

photolysis in cells, zebrafish, and Xenopus embryos.
Another method for using antisense oligonucleotides to achieve gene knockdown
is by caging siRNA to control RNA interference (RNAi)[27]. siRNAs are short RNA
duplexes comprised of 21-23 base pairs, which can be transfected into cells to achieve
mRNA degradation. After transfection, the strands bind to the RNA-induced silencing
complex (RISC), which removes the sense strand, aids in hybridization of target mRNA
to the antisense strand, and finally degrades the mRNA. In one of the earliest examples
of caged siRNA, the phosphate backbone of a siRNA duplex was labeled with the 1-(4,5dimethoxy-2-nitrophenyl)ethyl group; the duplexes were labeled with an average of 1.4
caging groups to block sterically the siRNA-RISC interaction before photolysis[28].
When the caged siRNA duplexes were co-transfected with a GFP plasmid into HeLa
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cells, a two-fold decrease in GFP fluorescence was observed post-photolysis.
Unfortunately, this technique of caging siRNA did not completely inhibit RNA
interference. This is likely because the caging is not site-specific, so some duplexes are
not modified, allowing them to bind the RISC.

Another potential negative is that

increasing the number of caging groups (which may be required to ensure all duplexes
are caged) requires longer irradiation times, and this can lead to phototoxicity. Longer
irradiation times also lead to loss of spatial and temporal resolution, which is relevant for
many biological applications. Still, this approach was used to label 2′-fluoro modified
siRNA duplexes with 7.9 caging groups per 21mer sense strand and nine caging groups
per 21mer antisense strand[29].

The 2′-fluorinated residues were used to increase the

enzymatic stability of the oligonucleotide in vivo.

This is because 2′-fluoro RNA

maintains the C3′-endo sugar pucker to preserve the A-form duplex required for RNAi
activity. In this example, only ~55% of GFP expression was silenced in cell culture after
photolysis, but this was an increase from the ~10% silencing observed prior to
irradiation. Additionally, the authors demonstrated that the caged 2′-fluoro modified
siRNA could decrease GFP expression after UV irradiation in zebrafish.
Another method developed to cage siRNA involves incorporation of a single
caging moiety at the 5′ terminal phosphate of the antisense strand because it has been
shown to be necessary for binding to the RISC complex[30].

In one example, a

nitrophenyl-ethyl (NPE) group was introduced at the 5′-phosphate, reducing siRNA
activity to 40% and allowing activity to be fully restored after UV irradiation[31].
Attempting to improve upon this approach, Shah et al. chose to incorporate 1-(4,5dimethoxy-2-nitrophenyl) ethyl (DMNPE) groups, but they discovered that this caging
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group preferentially labels the terminal phosphate groups of oligonucleotides, suggesting
that those groups were indeed modified in previous studies that sought to cage the
phosphate backbone[32].

In fact, their work suggests that the commonly employed

DMNPE group actually reacts poorly with backbone phosphates.

By labeling the

phosphate groups at the four termini of a siRNA duplex with DMNPE, they achieved up
to a six-fold decrease in gene expression. They hypothesize that the incomplete blocking
they observed before irradiation is due to Dicer developing a tolerance to the
modifications or to a cellular process that can remove the photocleavable groups.
To improve the nuclease stability of siRNA, phosphorothioate residues have been
incorporated while also using the DMNPE caging group[33]. With two phosphorothioate
linkages per strand at the termini of the duplex, the authors were able to decrease the
level of RNAi activity prior to uncaging. In this case, the phosphorothioate groups help
prevent nucleases from cleaving the DMNPE group from the oligo, keeping the duplex
blocked until near-UV irradiation.
Recent work by the Friedman group has focused on fully blocking RNAi activity
prior to photolysis[34]. With this aim, they developed a new photocleavable moiety,
cyclo-dodecyl (dimethoxy-2-nitrophenyl)ethyl (CD-DMNPE), which was designed to
completely block RNAi machinery from interacting with the siRNA. CD-DMNPE labels
the terminal phosphates just like the commonly used DMNPE, but this caging group is
bulkier due to the addition of a carboxyl synthetic handle and amine groups. The added
bulk at all four termini should sterically block Dicer or nucleases that could remove the
caging group.

When modified siRNA duplexes targeting GFP were tested in cell
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monolayers, they were completely blocked from participating in the RNAi pathway prior
to irradiation, but after photolysis, native activity was fully restored.
Additional work with other photocleavable groups, such as biotin, amines, or
linkage to the sense strand at the 5′-end of the antisense strand, have shown that these
approaches reduce siRNA activity, but they do not completely abolish it. This could
perhaps be because the caging groups only block one of the charges on the phosphate,
leaving another oxygen unmodified and potentially capable of binding to the RISC[35].
As demonstrated with other antisense oligonucleotide approaches, caged nucleobases
have been utilized to photomodulate siRNA activity. For instance, incorporation of
caged guanosine or thymidine at positions 9-11 of the antisense strand has led to
complete photomodulation of activity[36]. Because RNA cleavage occurs opposite the
tenth and eleventh residues of the antisense strand, this design results in a bulge that
inhibits RNAi, turning it completely off prior to irradiation. Activity is fully restored
post-photolysis.
d. Photoregulatable aptamers
Spatiotemporal control of aptamers is another application of light-switchable
oligonucleotides that has been developed.

Aptamers are short, single-stranded

oligonucleotides that fold into well-defined shapes upon binding to their target small
molecules. Heckel et al. employed caged thymidine nucleobases to photoregulate an
anti-thrombin aptamer[37]. They chose this 15mer ssDNA because it is one of the most
extensively studied aptamers to date, and it has a unique, stable G-quartet fold comprised
of six thymidine and nine guanosine nucleotides. By incorporating a single NPP-caged
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thymidine in different locations, it was discovered that thrombin did not interact with any
of the caged aptamers before irradiation, but binding was almost completely restored
after uncaging.
In

another

study,

a

coumarin

derivative,

6-bromo-4-diazomethyl7-

hydroxycoumarin (Bhc-diazo) was used to cage the phosphate backbone to control the
previously studied anti-thrombin aptamer[38]. With an average of 6.8 Bhc caging groups
per 15mer aptamer strand, the caged aptamer still had approximately 14% affinity for
thrombin; uncaging only restored up to 60% affinity compared to the unmodified
aptamer. While the aptamer’s activity was not fully restored post-photolysis, this caging
group does offer the advantages of synthetic ease of and two-photon uncaging potential.
In yet another study, a caged aptamer targeting cytohesin was designed[39]. This
study was interesting in that the authors were able to generate a light-controlled aptamer
without any prior knowledge of the structure or interactions of the aptamer with its target
protein. Cytohesin-1 was chosen as the target because in vitro selection methods aimed
at discovering an RNA aptamer towards it had already proven successful.

After

successful aptamer development, it was discovered that a single nucleotide caged with
either the NPP or NPE groups was sufficient to prevent the aptamer from binding
cytohesin-1.
e. Other photoactivatible oligonucleotides
Early photomodulation of oligonucleotides was developed to assist with
purification or characterization. Introduction of a nitrobenzyl moiety during solid-phase
synthesis allowed for the creation of light-induced strand breaks. This design allowed for
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tags, such as fluorophores and biotin, to be removed from the oligonucleotide by
photolysis when they are no longer necessary. The photocleavable groups can also be
incorporated as protecting groups during solid-phase synthesis[40]. Rather than using the
standard treatment of ammonium hydroxide to cleave oligonucleotides from solid support
and remove the protecting groups, irradiation can be used.

In 1996, Olejnik et al.

developed a photocleavable biotin (PCB) phosphoramidite to aid in purification and
phosphorylation of oligonucleotides[41]. The PCB was incorporated on the 5′-terminal
phosphate during solid-phase synthesis, allowing the full-length oligonucleotide to be
isolated via incubation with immobilized streptavidin. To attain the pure desired product,
the oligonucleotide was then irradiated with 300-350 nm light, which cleaved the PCB
moiety. In another study, a photocleavable spacer comprised of a 2-nitrobenzyl group
was introduced to connect a DNA strand to a fluorescein at the 5′-end[42]. By also
incorporating a 3′-biotin, the oligonucleotide was first immobilized on a streptavidincoated glass surface. After irradiating the sample with UV light and washing thoroughly,
the change in fluorescence before and after photolysis could be measured. This study
found an almost 80% decrease in fluorescence after photolysis and laid the groundwork
for utilizing a dye-labeled photocleavable nucleotide for DNA sequencing[43].
Strand breaks such as these have also been utilized to identify single base
mismatches. Since single nucleotide polymorphisms (SNPs) may be responsible for
some types of genetic diseases, a rapid and inexpensive detection method would be
highly useful. In one technique, a fluorescence detection assay was developed to identify
single-base mismatches by exploiting the lower melting temperatures of strands with
mismatches after photolysis[44]. A DNA strand with a centrally-located photocleavable
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group (5′-o-nitrophenyl thymidine) and a Disperse Red 1 detection tag at the 5′-end was
immobilized on agarose so that the target strand did not require modification in any way.
After hybridization of the target strands and UV irradiation, the tag remained bound to
the solid support in the case of a fully matched strand, but the red tag was released into
solution in the mismatched case. This assay was effective in detecting even a single
mismatch after a two hour hybridization and subsequent ten minute irradiation time.
Recently, caged oligonucleotides have been utilized in the development of
nanodevices. For example, an azobenzene-modified reversible DNA nanotweezer has
been developed[45]. When the azobenzene groups were in the trans configuration, the
tweezers were closed. Upon UV irradiation, the azobenzene groups isomerized, opening
the tweezers. DNA nanoscissors have also been brought under the control of light[46].
Work by Tsai et al. combined a nanoparticle core with a monolayer of hydrazonemodified triplex-forming oligonucleotides, which are able to capture and cleave their
target DNA duplex after irradiation at 460 nm.
Other caged oligonucleotides have been utilized to control PCR product
generation. The Deiters lab incorporated caged thymidine residues into DNA primers,
disrupting DNA hybridization until after photoactivation[47].

This allowed them to

temporally control activation of the PCR reaction. Additional work by Tanaka et al. also
controlled PCR with light via incorporation of a caged thymidine into a PCR primer[48].
The caged nucleotide was incorporated site-specifically to block DNA polymerase under
PCR conditions, so the elongation products of the PCR cycles before irradiation were
terminated at the caged residue. After UV irradiation to remove the NPP caging groups,
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sticky ends were created at the end of the PCR products. These products were then
ligated into an expression plasmid following digestion with restriction enzymes.
Additionally, photomodulation of nucleic acid folding has been achieved. Better
understanding of DNA and RNA folding can be useful for discovering important tertiary
contacts and for differentiating between local and global structure formation. Controlling
this folding with light may lead to real-time monitoring of folding kinetics. As a proofof-concept study, the Silverman lab incorporated 2-nitrophenyl ethyl (NPE) caged RNA
nucleotides to study the folding of Tetrahymena group I intron RNA, whose tertiary
structure is already well-defined[49]. Each of the four RNA nucleotides was caged, and
one caged base per RNA strand was incorporated strategically based upon the molecular
X-ray crystal structure. The caging groups were successful in disrupting global folding
of the RNA, and folding was restored upon photolysis. The Heckel group opted to probe
the G-quadruplex formation of a common sequence used for studying telomeric DNA[50].
Different dG nucleotides were replaced with NPP-caged ones, and it was discovered that
substitution of just one residue in the core of the sequence was enough to prevent Gquadruplex formation.
f. Indirectly photomodulated oligonucleotides
Toyocamycin, a small molecule inhibitor of a self-cleaving ribozyme, was caged
to control expression of a luciferase mRNA transcript[51]. In this design, a self-cleaving
ribozyme sequence was cloned into the 5′-UTR of a luciferase mRNA to test the efficacy
of the caged small molecule. In the presence of toyocamycin, the correct folding of the
ribozyme is inhibited. When the caged toyocamycin was co-transfected with the plasmid
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in cell culture, the self-cleaving ribozyme was able to cleave itself prior to irradiation,
resulting in degradation of the transcript and no luciferase expression. After irradiation,
toyocamycin was able to inhibit the ribozyme’s function, so the transcript was intact,
allowing for luciferase expression.
Another example is the light-activation of a riboswitch regulatory cofactor.
Riboswitches are non-coding RNAs that are usually located in the 5′-UTR of bacterial
genes. When a riboswitch binds to its cofactor, usually a metabolite, it undergoes a
conformational change, which results in control of gene expression.

Recently,

glucosamine-6-phosphate (GlcN6P), the cofactor for the glucosamine-6-phosphate
synthetase (glmS) riboswitch, was caged[52]. When the glmS riboswitch was cloned into
the 3′-UTR of an EGFP plasmid, the riboswitch retained its self-cleavage activity in the
presence of caged GlcN6P. However, after irradiation, the uncaged cofactor reduced the
amount of EGFP translated.
Photoregulatable cellular delivery is yet another example of indirect caging of
oligonucleotides. An example of this is the modification of cationic gold nanoparticles
with a nitrobenzyl group modification[53]. Prior to irradiation, DNA associates with
positively-charged nanoparticles with photoactive groups present. After UV irradiation,
the nitrobenzyl linkage is cleaved, leaving a negatively charged carboxylate group on the
nanoparticle. When this occurs, the negatively changed backbone of DNA is released
from the nanoparticle, resulting in gene expression being turned “on.”
In another report, Young et al. used spiropyran, as their light-sensitive small
molecule[54]. This chromophore is able to undergo rapid conformational changes to
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isomers of different colors. More specifically, in visible light conditions, spiropyran is
colorless; after irradiation with UV light, it switches to its purple merocyanine form.
Utilizing in vitro selection methods, an RNA aptamer capable of binding to one form of
spiropyran was engineered. Upon binding spiropyran, the conformation of the RNA can
be reversibly switched by applying UV light, resulting in release of the aptamer.
As these diverse examples and new advances (such as light-controlled molecular
beacons[55] and microRNA inhibitors[56]) demonstrate, there are multitudes of uses for
caged oligonucleotides. However, there are also a number of improvements that are still
necessary.

Next, the contribution our lab has made in advancing strategies for

photomodulating oligonucleotides will be discussed.
IV. Improving photoactivatable oligonucleotides
In some of the first examples of caging oligonucleotides, large excesses of caging
groups were used to non-specifically label many sites on plasmids and mRNA. In
addition to increasing the cost of synthesis, multiple caging groups are inefficient to
uncage and require longer irradiation times.

Our group aims to improve upon the

existing methods by developing new designs that only require one or two caging
moieties. We also incorporate them site-specifically to control oligonucleotide function.
Furthermore, we have introduced fluorescent reporters to verify photolysis.
One of our lab’s earliest approaches involved the synthesis of a DNA primer
strand with an adjacent photocleavable fluorophore-quencher pair which prevented
extension of the primer by DNA polymerase[57].

In this design, the quencher was

removed after photolysis (which was confirmed by an increase in fluorescence) and the
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primer was extended (Figure 1.3). In additional work by our lab, Dr. XinJing Tang
developed a novel method for controlling oligonucleotide hybridization[58]. Using a
single photocleavable linker to join an antisense DNA to its complementary strand, he
was able to block the DNA from binding to its normal RNA target. The photocleavable
linker includes a malemide for reaction with thiols and an NHS ester for reaction with
amines.

The DNA and blocking strands were synthesized with amine and thiol

modifications to facilitate reaction with the linker after synthesis (Figure 1.4). Before
photolysis, the complementary strand has a high melting temperature because it is
covalently attached to the DNA, but after UV irradiation, the strand is no longer attached
and can dissociate. This allows the DNA to bind its target RNA, which is significantly
longer than the complementary strand. These photoactivatable DNA hairpins were then
used to regulate RNase H-mediated RNA digestion in cells[59]. This work was further
extended to another antisense oligonucleotide, negatively charged peptide nucleic acid, to
photoregulate the expression of bozozok and chordin genes in zebrafish embryos[60]. The
DNA hairpin design necessitates a balance between a high melting temperature between
the DNA and blocking strand before photolysis and a low melting temperature afterwards
so that the DNA will hybridize preferentially to the RNA and not to the blocking strand.
Therefore, optimization was required to determine the length and position of the blocking
strand.
While DNA hairpins are useful for turning gene expression “off” after photolysis,
Dr. Julia Richards, a previous graduate student in our lab, thought it would be equally
useful to turn gene expression “on.” Based on this premise, she sought to develop RNA
bandages which are comprised of two 2′-O-methyl (2′-OMe) RNA strands joined by the
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aforementioned photocleavable linker[61]. In this design (Figure 1.5), 2′-OMe RNA was
employed because previous work studying structural modifications to antisense
oligonucleotides that would improve mRNA binding affinity and specificity discovered
that this modification of the RNA ribose ring improves both nuclease resistance and
mRNA hybridization[62].

The design of RNA bandages enabled them to bind their

mRNA target at the start codon and Kozak sequence in the 5′-UTR to block translation
until uncaging.

Because the timing and location of protein expression in cells are

important, controlling these factors could shed light on the function of genes of interest.
In this design, the melting temperatures of the two short, tandem oligonucleotides are
significantly lowered after photolysis when compared to the caged oligonucleotide. This
decreased affinity for the target allows them to melt off the mRNA, allowing the
ribosome to bind and translate the mRNA. While the best bandage design resulted in a
three-fold increase in translation after photolysis, there were drawbacks to this design.
During bandage optimization, it was discovered that there was not a simple correlation
between the change in melting temperature and a bandage’s ability to block translation.
This could make it difficult to design bandages for sequences with poorly understood
secondary structures.
Additional work by Dr. Richards centered around photoregulating the 10-23
DNAzyme[63].

While the 10-23 DNAzyme had been site-specifically regulated

previously using caged bases, our lab aimed to turn its activity on and off using a
photocleavable spacer. The advantage of this approach is that the photocleavable spacer
is commercially available as a phosphoramidite, eliminating the need to perform a
lengthy synthesis of caging an individual nucleotide phosphoramidite. This also allows
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for the photocleavable group to be incorporated at any desired position within the
oligonucleotide. In order to turn the DNAzyme’s activity “off,” two photocleavable
spacers were incorporated within the DNAzyme, one in a binding arm and one within the
catalytic core (Figure 1.6). To create a DNAzyme that can be turned “on,” a circular
DNAzyme linked to a complementary strand with two photocleavable spacers was made.
After UV irradiation, the blocking strand melts off the DNAzyme, leaving the enzyme
free to bind and cleave its target RNA. These strategies should facilitate the development
of DNAzymes for numerous uses in biotechnology.
V. Research Aims
Work presented in this dissertation demonstrates novel ways of caging
oligonucleotides. In chapter two, a new method for photoregulating a 10-23 DNAzyme
and characterization of its catalytic loop are discussed[64]. The third chapter presents a
new design for improving caged hairpins with the addition of a second photocleavable
linker and a FRET pair (to monitor dissociation post-photolysis) along with results from
its application in neurobiology.

Finally, a new technique for caging siRNA by

enzymatically circularizing it is proposed, and the initial synthesis, purification, and
ligation schemes are presented.
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Figure 1.1 Caged ATP structure and photolysis.
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Figure 1.2 Structures of caging moieties commonly used for oligonucleotides. Wavy
lines indicate the point at which the oligonucleotide is attached. A) Nitrobenzyl group
and common derivatives, B) Coumarin group with derivatives, and C) Azobenzene.

30

Figure 1.3 A) Strategy for photoregulation of primer extension using Klenow fragment
(KF). Adjacent cytidines were modified with fluorescein (green)) and a photocleavable
dabsyl (red) prevent DNA polymerase from extending the primer. UV irradiation
removes dabsyl, which
ich allows KF to elongate the primer and fluorescein to fluoresce
green. B) Structure
tructure and photolysis products of photocleavable dabsyl.
This figure was adapted from X. Tang et al. Bioorg. Med. Chem. Lett., 2005, 15, 53035306.
A)
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Figure 1.4 A) Scheme for the design of light
light-activated DNA hairpins. An antisense
oligonucleotide (red) is blocked from binding mRNA (purple
(purple) by a complementary strand
(black) joinedd by a photocleavable linker (green
(green).. The length and position of the
complementary blocking
locking strand can be varied to optimize hybridization. After
photolysis, the antisense oligonucleotide is liberated, allowing it to bind its mRNA target.
target
B) Structure of the heterobifunctional linker
linker.
This figure was adapted from X. Tang et al. Angew. C
Chem. Int. Ed., 2006,
2006 45, 3523-3526.
A)

B)
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Figure 1.5 General strategy for making caged RNA bandages. Bandages comprised of
two short 2′-OMe RNA strands complementary to an mRNA target are linked via a
photocleavable linker. Before irradiation, the bandages blocked translation. After
photolysis, the strands melt off, restoring translation.
This figure was adapted from J. Richards et al. Bioorg. Med. Chem. Lett., 2008, 18,
6255-6258.
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Figure 1.6 Design for photoregulating the 10-23 DNAzyme. A) Two photocleavable
groups (gray box) placed in the binding arm and catalytic core of a DNAzyme prevent
the enzyme from cleaving RNA after UV irradiation. B) A circular DNAzyme linked to
a complementary strand via two photocleavable spacers cannot cleave its RNA substrate
until activity is restored with UV light.
This figure was adapted from J. Richards et al. ChemBioChem., 2010, 11, 320-324.
A)

B)
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Chapter 2
Mismatch discrimination and efficient photomodulation of split
10-23 DNAymes
This chapter was adapted from B.K. Ruble et al. Inorg. Chim. Acta, 2012, 380, 386-391.
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I. Introduction
Since Breaker and Joyce’s report of an RNA-cleaving DNAzyme in 1994[1],
DNAzymes have become important biochemical tools[2] and have been utilized for
applications as diverse as RNA ligation[1] and Diels-Alder reaction catalysis[3].
Additionally, recent advances have succeeded at creating DNAzymes that are promising
biosensors[4] and potential therapeutic agents for gene suppression[5]. Furthermore, by
cloning the 10-23 DNAzyme into a plasmid, progress has been made in creating
DNAzymes that do not require exogenous delivery[6].
One of the most widely studied DNAzymes is the 10-23 DNAzyme, which can
cleave RNA at a junction between purine and pyramidine bases, preferentially A–U[7].
The 10-23 DNAzyme structural motif consists of a 15-nucleotide (nt) catalytic loop
flanked by two 6-12-nt binding arms that are complementary to the RNA target (Figure
2.1). Enzyme activity is dependent on divalent metal ion binding to the catalytic loop[1,
8]

. The catalytic loop has been studied by deletion[9] and mutation[10] of residues, and by

substitution of the backbone phosphates with phosphorothioates[11].

However, the

structure of the loop and its catalytic mechanism require further characterization. The
existing crystal structures are not believed to represent the active conformation of the
loop, which is likely very flexible[12].

Our lab’s recent discovery that the 10-23

DNAzyme can work as two separate ‘a’ and ‘b’ strands (Figure 2.1) exemplifies this
flexibility[13].

Here, we sought to expand our understanding of the structural

requirements of the split 10-23 DNAzyme and investigate its potential for mismatch
discrimination and photoregulation.
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The ability to function in two parts is not unique to the 10-23 DNAzyme, as it has
also been demonstrated with peroxidase-like DNA enzyme[14], DNAzyme E6[15], and
deoxyribozyme ligase[16].

Furthermore, multi-component nucleic acid enzymes

(MNAzymes), which become catalytically active when an assembly facilitator is added to
the partial enzymes, have been developed[17]. Additionally, two-component DNAzymes
consisting of 2′-O-methylribonucleotide effectors and 10-23 DNAzymes with shortened
3′ binding domains have been engineered[18]. These notable examples motivated us to
investigate further the structural requirements of the 10-23 DNAzyme.
We chose a DNAzyme with binding arms that target VEGFR2 RNA, which was
shown previously by Zhang et al. to achieve gene knockdown in cell culture and mice[5a].
We determined that this full-length DNAzyme exhibits activity even at low
concentrations of the requisite divalent metal ion. This favors its use for in vivo studies,
and also provides a useful platform for designing split DNAzymes. We explored the 1023 DNAzyme’s functionality as separate strands by dividing the enzyme between
different residues of the catalytic loop to generate fourteen split DNAzymes, Dz1-Dz14
(Figure 2.1). The split DNAzymes cleaved RNA with efficiencies that depended on
where the loop was divided. Split DNAzymes divided at the middle of the catalytic loop
(Dz7, Dz8) showed activity comparable to the full-length enzyme (Dz0). Because of the
short length of the binding arms (9-nt), the split enzymes were more sensitive than Dz0 to
single base mismatches with the target RNA. Much higher metal ion concentrations were
required to maintain activity than observed with the full-length DNAzyme.
After determining the best cleaving half enzymes, we aimed to design a
photoregulatable DNAzyme that could be turned “on” upon irradiation. RNA-cleaving
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DNAzymes, such as the 10-23 DNAzyme, have been demonstrated to be promising gene
silencing agents[5a,

19]

, motivating the development of light-controlled DNAzymes for

possible biological applications[5b]. In a pioneering example[20], Lusic et al. disrupted
DNAzyme function by incorporating photoresponsive bases within the 8-17 and 10-23
DNAzymes using phosphoramidite chemistry. When the DNAzymes were photolyzed,
the caging groups were removed, which activated enzyme activity and turned gene
expression “off”. Additionally, DNAzymes that can be activated and deactivated with
light in mammalian cells have been developed[19]. To achieve this, caged thymidine
residues were site-specifically incorporated within the DNAzyme or a DNA decoy strand.
In order to turn DNAzyme function from “on” to “off,” caged DNA decoys or hairpin
DNAzymes with thymidines in positions that prevent hairpin formation prior to
irradiation were employed. To activate the DNAzyme, caged residues were incorporated
within the catalytic loop to prevent the DNAzyme from cleaving RNA or within the
binding arms to prevent hybridization to the target.
While several techniques for turning DNAzyme function from “on” to “off” have
been developed[13, 19], there are fewer that allow DNAzyme function to be turned “on”[21]
using a single photoactive group[21a, 21c], as we have shown can achieve very efficient
photomodulation of oligonucleotide function[22]. Ting et al. pioneered the design of a
photoregulatable DNAzyme with a single caging moiety, however the 280 nm light
required to activate this enzyme is undesirable for most biological studies[21c]. The
photoswitchable DNAzyme designed by Keiper et al. incorporated a single azobenzenemodified nucleotide in the catalytic loop[21a]. We previously discovered that the activity
of the full-length 10-23 DNAzyme can be turned from “off” to “on” upon 365 nm
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irradiation by attaching a complementary strand via two photocleavable linkers and
circularizing the conjugate using Circligase[13]. Similar approaches employing a single
photocleavable linker joining an oligonucleotide to a complementary blocking strand
have been designed[22c,

23]

. In our previous approach, the DNAzyme was no longer

covalently bound to the blocking strand after near-UV irradiation, allowing it to cleave its
RNA target. However, native activity was not fully restored post-photolysis, based on
lingering hybridization of the DNAzyme to the sense strand. This motivated the search
for alternate photoregulation approaches.

Previous work by Stojanovic et al. showed

that incorporating a biotinylated dT in deoxyribozyme E could block activity in the
presence of streptavidin[24]. Similarly, a biotinylated caging agent was used to recruit
streptavidin to block transcription factors from binding to a promoter sequence of an
expression plasmid[25]. In our study, efficient photoregulation of a biotinylated split 1023 DNAzyme was achieved by employing streptavidin to disrupt the active conformation.
Unlike in previous strategies, the DNAzyme with photocleavable biotin can be
constructed entirely from commercially available reagents in high yield using solid-phase
DNA synthesis.
II. Experimental procedures
a. RNA cleavage by DNAzymes
Single turnover reactions (total volume 24 µL) were performed at 37 °C with 50fold excess of DNAzyme to RNA substrate. DNAzyme (4.2 µM) and 0.083 µM P-32
labeled 28-nt RNA substrate (5′-GCGCGAGGUGCAGGAUGGAGAGCAAGGC-3′, A–
U cleavage site highlighted in bold) were reacted in standard buffer, defined here as 10
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mM Tris buffer (pH 7.5) with 10 mM MgCl2 and 83 mM NaCl. Oligonucleotides were
obtained from Integrated DNA Technologies. Aliquots (4 µL) were removed after one
hour, at which point the reaction was quenched with 6 µL RNA loading buffer II
(Ambion). The aliquots were analyzed by polyacrylamide gel electrophoresis (PAGE)
using a 7 M urea, 20% polyacrylamide gel at 300 V for 40 minutes. Gels of RNA
digestion were imaged using an Amersham Biosciences Storm 860 phosphorimager.
Gels were subsequently analyzed using TotalLab Software (Nonlinear Dynamics) to
detect the band intensities and correct for background using the rubber band subtraction
function. Finally, the ratio of intensities of the uncleaved and cleaved RNA bands was
calculated.
b. Thermal denaturation of DNAzyme-RNA hybrids
Thermal denaturation studies were conducted in standard buffer with a 19-nt
RNA sense strand (5′-AGGUGCAGGAUGGAGAGCA-3′) (1 µM) incorporating a noncleavable 2′-O-methylated (2′-OMe) adenosine (highlighted in bold) at the typical
scission site. To hybridize the split DNAzyme (1 µM) to this RNA target, solutions were
heated to 95 °C for five minutes in a water bath and then allowed to cool to room
temperature. Melting studies were conducted on a Beckman Coulter DU800 UV-Vis
spectrophotometer equipped with a programmable Peltier temperature controller.
Samples were monitored at 260 nm while being heated or cooled at a rate of 1.0 °C min-1,
with a one minute hold per degree Celsius. Melting temperatures were determined from
the peak of the first derivative plot of A260 versus temperature.
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c. Circular dichroism spectroscopy of DNAzyme-RNA hybrids
Circular dichroism (CD) spectroscopy was performed using an Applied
Photophysics Chirascan instrument. Samples of 2 µM DNAzyme and 2 µM 19-nt noncleavable 2′-OMe RNA target were prepared in standard buffer. Samples were preannealed by heating to 95 °C for five minutes and cooling slowly to room temperature.
d. Photoactivation of biotinylated split DNAzymes
The RNA cleavage assay (total volume 24 µL) was performed in standard buffer
with equimolar DNAzyme halves Dz7a or Dz8a (4.2 µM) and photocleavable 5′biotinylated Dz8b. The solution was irradiated by UV transilluminator (9 mWcm-2 at 365
nm) for 20 minutes.

Non-irradiated control reactions were also prepared.

Next,

streptavidin (100 pmol, equimolar with DNAzyme) was incubated in the reaction mixture
at 37 °C for 30 minutes, P-32 labeled RNA substrate (0.083 µM) was added, and the
reaction was allowed to proceed for one hour at 37 °C. Aliquots (4 µL) were analyzed by
PAGE as described above.
III. Results and discussion
a. Split DNAzyme characterization
The full-length 10-23 DNAzyme in this work (Dz0) has 18 bases complementary
to the target RNA, while the split DNAzymes have separate binding arm regions that are
each just nine nucleotides long.

Thermal denaturation experiments (Figure 2.2)

confirmed that the split DNAzymes produce lower melting temperatures, relative to Dz0,
when hybridized to a 19-nt non-cleavable RNA target. Melting temperatures (Tm) for
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Dz1-Dz14 ranged from 54 °C to 57 °C, compared to 65 °C for Dz0. We also performed
circular dichroism (CD) spectroscopy of Dz8, Dz0 and DNAzyme halves Dz8a or Dz8b,
hybridized to the same non-cleavable RNA target (Figure 2.3).

CD spectra of the

DNAzyme-RNA hybrids (Figure 2.3) agreed with the previously published CD spectrum
of Dz0 by Cieslak et al[26]. The asymmetric peak at 270 nm, the negative effect at 244
nm, and the peak at 223 nm are characteristic of DNAzyme-RNA hybrids[26], and are also
consistent with our previous characterization of Dz0[13].
b. Activity of split DNAzymes
We tested mixtures of split DNAzymes lacking the internal phosphate group,
where the DNA was divided into hydroxyl-terminated ‘a’ and ‘b’ strands at every residue
of the catalytic core (Figure 2.1C). The reaction was initiated upon addition of RNA to
the DNA ‘a’ and ‘b’ strands, without pre-incubation. The large excess of DNAzyme was
used to find reaction conditions with even low-level activity, in order to guide enzyme
optimization.
Dividing the catalytic loop between nucleotides 7 and 8 (Dz7), 8 and 9 (Dz8), 11
and 12 (Dz11), and 12 and 13 (Dz12) produced very functional split DNAzymes. Dz11
and Dz12 cleaved greater than 25% of the RNA target after one hour incubation, whereas
the most efficient split enzymes (Dz7, Dz8) cleaved approximately 50% (Figure 2.4).
Under the same conditions, the full-length enzyme (Dz0) cleaved 75% of the RNA target.
Split DNAzymes divided between nucleotides 6 and 7 (Dz6), 9 and 10 (Dz9), 13 and 14
(Dz13), and 14 and 15 (Dz14) cleaved 4-10% of the RNA. Dividing the DNAzyme at
other loop positions did not produce measurable activity.
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c. Metal ion requirements of split DNAzymes
To investigate further the functionality of the split catalytic loop, we tested the
activity of Dz0 and Dz8 in the presence of various divalent metal ions. While the 10-23
DNAzyme was originally discovered to be Mg2+ dependent, studies have shown a T8
mutant has comparable activity with Ca2+[9]. We found that Dz0 and Dz8 were able to
cleave the RNA target in the presence of Mg2+, Mn2+, and Ca2+, with Dz8 somewhat less
active in each case (Figure 2.5). Furthermore, the split enzymes were found to have
similar melting temperatures with each of these metal ions (Figure 2.2). We also tested
DNAzyme activity with Na+ ion to rule out any contribution of this monovalent cation to
RNA cleavage. Finally, Zn2+ was found to elicit no activity in Dz0 or Dz8, as has been
seen previously with the 10-23 DNAzyme[8]. Next, we varied the concentration of Mg2+
ion to determine the optimal RNA cleavage conditions. Reactions with Dz0 resulted in
significant cleavage with Mg2+ ion concentrations as low as 0.01 mM. Neither Dz0 nor
Dz8 were active when no Mg2+ was added to the buffer (Figure 2.5). However, Dz8
showed modest activity at 3 mM Mg2+ and showed high activity only at concentrations
above 5 mM Mg2+ (Figure 2.6). The requirement for much higher magnesium ion
concentration (in the background of high ionic strength standard buffer) suggests that the
split DNAzymes have lower affinity for Mg2+ ions that are critical for catalytic activity.
The finding that the full-length DNAzyme is still active at 0.01 mM Mg2+ was
initially surprising, as Cieslak et al. previously discovered that the 10-23 DNAzyme
targeting β3 Integrin mRNA is only active at Mg2+ concentrations at or above 0.5 mM[26].
Concerns that residual Mg2+ ions may remain after the T4 polynucleotide kinase reaction
to P-32 label the RNA substrate led us to test the ability of the DNAzyme to cleave a
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non-labeled RNA substrate (Figure 2.7).

This experiment confirmed our previous

findings, as the full-length enzyme was still able to cleave the RNA substrate. While this
activity at low Mg2+ concentration was unexpected, it is noteworthy that successful
cellular experiments by Zhang et al. were performed with the same DNAzyme employed
in our work[5a].

Since this DNAzyme was able to function at intracellular Mg2+

concentrations, which are approximately 0.5 mM for free Mg2+, it is conceivable that it
could exhibit catalytic activity at the low concentration demonstrated here.

The

difference in Mg2+ requirements for these different 10-23 DNAzymes may be due to
differences in binding arm sequences. This hypothesis is supported by a previous study
which discovered that two DNAzymes that both target telomerase mRNA have large
differences in their optimal Mg2+ concentrations[27]. One enzyme is most efficient at 1
mM and the other at 20 mM. Upon further investigation, the enzymes showed little
difference in Mg2+ requirements once the DNAzymes had hybridized to their targets.
d. Split DNAzyme mismatch detection
To assess mismatch discrimination, we tested both the full-length DNAzyme
(Dz0) and the split DNAzyme with the highest activity (Dz8) by introducing one
noncomplementary base at different positions within the binding arms of both enzymes
(Table 2.1). Gel electrophoresis showed that the intact 10-23 DNAzymes were able to
cleave the 28-nt RNA target efficiently in all cases, with the original, full-length
DNAzyme sequence (Dz0, Table 2.1) yielding very similar cleavage efficiencies to the
seven full-length mismatch sequences (m1-m7, Table 2.1). Yields of RNA cleavage
ranged from 70-80% for most sequences tested, but decreased to 50-60% when the
mismatch was closest to the catalytic loop, in m3 and m4 (Table 2.1, Figure 2.8A).
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By comparison, considerably higher mismatch discrimination was observed for
the split DNAzymes. The seven split DNAzymes with mismatch sequences (m1-m7)
demonstrated significantly less RNA cleavage relative to the comparable full-length
DNAzymes in all cases, with greater than 20% cleavage observed only for split
DNAzymes m1, m6, and m7 (Table 2.1, Figure 2.8B).
e. Photoactivatable split DNAzyme
Having determined that Dz7 and Dz8 give the highest activity among the split
DNAzymes, we hypothesized that split DNAzyme activity could be inhibited by placing
a biotin moiety near the center of the catalytic loop (Figure 2.9A). We incorporated a
photocleavable biotin at the 5′ end of Dz8b and performed the standard cleavage reaction
by adding Dz8a and the 28-nt RNA target. A small amount of DNAzyme activity was
retained when biotinylated Dz8b was paired with Dz8a (Figure 2.10). However, when
the biotinylated split DNAzymes (Dz7a + Dz8b or Dz8a + Dz8b) were incubated with
streptavidin, all catalytic activity was lost (Figure 2.9C). We tested Dz7a because our
previous study demonstrated that substituting the thymine in position 8 in the catalytic
loop with a photocleavable spacer resulted in a highly active enzyme upon photolysis[13].
Activity was restored by irradiating at 365 nm, which cleaved the biotin moiety
and allowed separation from the streptavidin blocking agent. Interestingly, DNAzyme
activity was restored to 60% RNA cleavage for Dz7a and 39% RNA cleavage for Dz8a
upon photolysis (Figure 2.9C). This increased activity with Dz7a and Dz8b has been
seen previously when residues within the full-length 10-23 DNAzyme were replaced with
a photocleavable spacer and then irradiated[13]. Notably, the 60% activity observed post-
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photolysis for Dz7a + Dz8b equates to complete restoration of native activity for this split
DNAzyme. In this example, we succeeded in turning the DNAzyme from completely
“off” (< 1 % activity) to completely “on”, with no apparent interference from the biotinstreptavidin pair. The recovery of activity when Dz8b was no longer covalently linked to
biotin-streptavidin suggests a lack of non-specific binding of streptavidin to the
oligonucleotides or metal ions in solution.

An added benefit of regulating a split

DNAzyme rather than Dz0 is that the split enzymes retain their sensitivity to single base
mismatches post-photolysis (Figure 2.11).
IV. Conclusions
In conclusion, we have demonstrated that the best split DNAzymes (Dz7, Dz8)
are nearly as active as the full-length DNAzyme (Dz0) (Figure 2.4). Our discovery that
the most active split enzymes are those divided after the 7th or 8th nucleotide is consistent
with earlier observations that the full-length DNAzyme best tolerates mutations and
deletions closest to the center of the catalytic core[10]. This flexibility of the catalytic loop
is not unique to the 10-23 DNAzyme: studies of the 8-17 DNAzyme have demonstrated
that its catalytic domain can be modified to contain only guanosine and cytodine residues
while still retaining detectable enzymatic activity[28], and an extensive mutational analysis
of its catalytic core has shown the ability to retain activity[29]. Additionally, we have
established that the full-length 10-23 DNAzyme targeting VEGFR2 mRNA is capable of
retaining enzymatic activity at Mg2+ concentrations as low as 0.01 mM, providing support
for the use of DNAzymes in cellular studies. We further demonstrated that the recently
discovered ability of DNAzymes to function as split enzymes imparts greater selectivity
towards the RNA target. Tuning the affinity of the short ‘a’ and ‘b’ strands provides a
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route for achieving even higher single-base mismatch selectivity. In addition to our
experiments with the split 10-23 DNAzyme, Kolpashchikov developed a split
peroxidase-like DNAzyme to be used for colorimetric detection of SNPs[15a]. Finally,
because photochemical approaches for modulating gene expression have many potential
uses in biological systems[30], we were interested in exploring the utility of
photocleavable biotin. Our approach incorporates a photocleavable biotin moiety at a
position within the DNAzyme that can tolerate substitution. In the case of the Dz7a +
Dz8b split DNAzyme, we showed complete blockage by streptavidin and then complete
restoration of activity upon biotin photo-release. The ability of the 10-23 DNAzyme to
function in two parts creates flexibility, with new avenues for controlling its function.
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Figure 2.1 A) General scheme for the formation of active DNAzyme from two separate
DNA strands. B) Sequences of RNA target (red), full-length DNAzyme (Dz0, with sticky
arms in black and catalytic loop in blue). C) Sequences of Dz0 and split DNAzymes
(Dz1-Dz14), with loop residues indicated in blue.
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Figure 2.2 Melting temperature data for DNAzymes hybridized with 19-nt RNA target
with a 2′-OMe adenosine at the cleavage site. Melting temperature studies were
performed in standard DNAzyme buffer (10 mM Tris buffer, pH 7.5, with 10 mM MgCl2
and 83 mM NaCl). For studies testing different metal ions, the 10 mM MgCl2 was
replaced with 10 mM CaCl2, MnCl2, ZnCl2,or NaCl. Melting temperatures could not be
determined with MnCl2 or ZnCl2.
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Figure 2.3 Circular dichroism spectroscopy was performed in standard DNAzyme buffer
with 2 µM DNAzyme and 2 µM 19-nt RNA target with a 2′-OMe adenosine at the
cleavage site. Samples were pre-annealed by heating to 90 °C and cooling slowly to
room temperature. The asymmetric peak at 270 nm, the negative effect at 244 nm, and
the peak at 223 nm are characteristic of DNAzyme / RNA hybrids.
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Figure 2.4 P-32
32 labeled RNA visualized by 7 M urea, 20% PAGE after
afte one hour
reaction with full-length
length Dz0 and split DNAzymes, Dz 11-Dz14.
Dz14. Dz7, Dz8, Dz11, and
Dz12 cleaved greater than 25% of ta
target
rget RNA. Data are averages of three independent
trials, with bars indicating the range of values.
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Figure 2.5 Cleavage of the 28-nt RNA substrate by Dz0 or Dz8 was investigated in the
presence of various metal ions. P-32 labeled RNA was imaged on 7 M urea, 20%
polyacrylamide gel after 1 h reaction with DNAzymes. Single turnover assays were
performed at 37 °C with 4.2 µM DNAzyme, 0.083 µM RNA in standard buffer with 10
mM MgCl2, MnCl2, CaCl2, NaCl, or ZnCl2.
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Figure 2.6
P-32 labeled RNA substrate on denaturing polyacrylamide gel
electrophoresis (20% PAGE / 7 M urea). Cleavage reactions were performed as
described previously. Standard DNAzyme buffer was substituted with buffers of various
Mg2+ concentrations.
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Figure 2.7
Full-length 10-23 DNAzyme and RNA substrate on denaturing
polyacrylamide gel electrophoresis (20% PAGE / 7 M urea). Single turnover assays were
performed at 37 °C with a 50-fold excess of DNAzyme to RNA (1000 pmol : 20 pmol) in
standard buffer with 10 mM or 0.01 mM MgCl2. After one hour, the reaction was
quenched with 10 µL RNA loading buffer II (Ambion). The gel was stained with
ethidium bromide for analysis.
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Table 2.1 Ratio of RNA target cleaved by the intact (Dz0) and split (Dz8) DNAzymes,
which also incorporated single base mismatches within the binding arms. These seven
new sequences are labeled m1-m7, with mismatch sites underlined and shown in bold
font. The gap in the middle of the sequences reflects where the split DNAzymes were
divided.

DNAzyme Sequences

Dz0: tgctctccaGGCTAGCTACAACGAcctgcacct
Dz8: tgctctccaGGCTAGCT ACAACGAcctgcacct
m1: tgctctccaGGCTAGCT ACAACGAcctgcacca
m2: tgctctccaGGCTAGCT ACAACGAcctgaacct
m3: tgctctccaGGCTAGCT ACAACGAactgcacct
m4: tgctctcaaGGCTAGCT ACAACGAcctgcacct
m5: tgctcaccaGGCTAGCT ACAACGAcctgcacct
m6: tgcactccaGGCTAGCT ACAACGAcctgcacct
m7: agctctccaGGCTAGCT ACAACGAcctgcacct

RNA
Cleavage
Intact Dz :
Split Dz
1.5
2.8
9.8
5.2
4.1
4.4
3.1
2.0
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Figure 2.8 A) Full-length DNAzymes with single-base mismatches (m1-m7) show
comparable activity to Dz0, which is fully complementary to the RNA target. B) Split
DNAzymes with single-base mismatches (m1-m7) cleave greater than 20% of RNA only
when the mismatch minimally perturbs hybridization, at either the 5′ or 3′ end.
Sequences of enzymes with single base mismatches are provided in Table 1. Data are
averages of three independent trials, with bars indicating the range of values.
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Figure 2.9 A) Schematic of general structure and function of photoactivatable
DNAzyme controlled by biotin-streptavidin interaction. B) Structure of biotinylated
photocleavable spacer. C) Photocleavable DNAzyme assay. Photocleavable biotinylated
Dz8b and streptavidin were added to either Dz7a or Dz8a. Samples were irradiated by
UV transilluminator (9 mWcm-2 at 365 nm) for 20 minutes prior to addition of RNA.
Reactions were incubated at 37 °C for one hour.
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Figure 2.10
P-32 labeled RNA substrate on denaturing polyacrylamide gel
electrophoresis (20% PAGE / 7 M urea). Cleavage assay was performed as described
previously. The Dz8b half with a 5′-photocleavable biotin was used instead of the
normal Dz8b.
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Figure 2.11
P-32 labeled RNA substrate on denaturing polyacrylamide gel
electrophoresis (20% PAGE / 7 M urea). Cleavage assay was performed as described
previously. The Dz8b half with a 5′-photocleavable biotin was used instead of the
normal Dz8b. Dz7a or Dz8a with single base mismatches incorporated (Table 1) were
tested. All samples were irradiated by UV transilluminator (9 mWcm-2 at 365 nm) for 20
minutes. Streptavidin (100 pmol, equimolar with DNAzyme) was incubated in the
reaction mixture at 37 °C for 30 minutes, P-32 labeled RNA substrate was added, and the
reaction was allowed to proceed for one hour at 37 °C.
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Chapter 3
Caged hairpin-bandage hybrids for transcriptome in vivo analysis
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I. Introduction
a. Background
The caged hairpins and bandages previously developed by our lab accomplished
their basic purposes, but they both required a good deal of optimization to achieve high
melting temperatures before photolysis and lower ones afterwards. Unfortunately, there
were also a number of other factors that determined how well each of these designs
controlled gene expression. For instance, there was no direct correlation between the
change in melting temperature of the DNA hairpin and its ability to photo-regulate RNase
H-mediated digestion of RNA[1]. Specifically, a variety of hairpins all comprised of the
same 20mer antisense sequence but different lengths of blocking strands and different
numbers of mismatched bases were synthesized. When the hairpins were tested in vitro,
it was discovered that the size of the loop formed by the photocleavable linker in joining
the DNA to its blocking strand was a more important factor. A similar problem was
encountered with the RNA bandages; the bandages with the largest changes in melting
temperature before and after photolysis were not the most effective in regulating gene
expression.

The targeted region of mRNA was found to be more significant than

thermodynamics[2].
Due to the complexity of the biological systems we wish to study and the abovementioned factors that require optimization, it is difficult to determine the effectiveness
of a given caged oligonucleotide. This led us to combine the hairpin and bandage
techniques to develop hairpin-bandage hybrids that would not require as much
optimization of the length and sequence of the blocking strands. By combining these two
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approaches, we designed an antisense strand that is linked via a photocleavable spacer to
a blocking strand that is divided into two parts by a second photocleavable spacer. After
UV irradiation, the blocking strand is broken into two shorter oligonucleotides, which can
more easily dissociate from the antisense strand. This design allows the blocking strand
to be as long as possible before uncaging, efficiently blocking the antisense strand from
binding to its mRNA target.
Previous work by our lab has concentrated on utilizing caged oligonucleotides to
gain control of gene expression. However, the hairpin-bandage hybrids are being utilized
to isolate mRNA from single neurons in culture and in mouse hippocampal slices. For
this work, we have been collaborating with the Eberwine lab in the Department of
Pharmacology at the University of Pennsylvania.
Research in the Eberwine lab focuses on studying RNA populations in neurons to
gain a better understanding of central nervous system function and to learn how neurons
respond to stimuli at the transcriptional level. Studying RNA populations from single
cells is important because, even though all cells contain the same DNA, their function
and morphology differ greatly. It has been shown that these phenotypic differences are
associated with which RNAs are present and the level at which they are expressed[3].
Unfortunately, it is very difficult to transfect single cells in a large population of cells
using existing methods. Therefore, a photoregulatable antisense oligonucleotide that
could be transfected into an entire populations of cells but uncaged site-specifically in a
single cell would be a valuable tool.
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b. Current techniques for isolating neurons
To date, there are a number of approaches for studying complex brain tissue.
These include fluorescence activated cell sorting[4], immunopanning[5], translating
ribosome affinity purification[6], manual sorting[7], laser capture microdissection[8],
atomic force microscopy nanoprobe extraction[9], and isolation via patch pipette[10].
Fluorescence activated cell sorting (FACS) was utilized to purify a genetically labelled
population of neurons[4]. A transgenic mouse line, in which the mice contained an EGFPexpressing cell-type-specific regulatory element, was developed. Hippocampal slices
from these mice were then enzymatically dissociated, and the neurons were subjected to
FACS purification. This process separated out only the neuronal population expressing
EGFP, allowing for isolation of RNA from only the neuronal subtype of interest.
Another method used to better understand brain development and function is
immunopanning[5]. With this technique, brain cells suspended in buffer are added to an
antibody-coated panning plate to remove cell types that adhere to the selected antibody.
Sequential panning with additional antibodies is performed until the desired neural cell
population, the oligodendrocyte lineage in this example[5], is isolated.
Translating ribosome affinity purification (TRAP) is another process for purifying
RNA from neurons. Heiman et al. developed the TRAP methodology, which initially
involves the development of a mouse line that expresses a transgene encoding EGFP
fused to a ribosomal protein[6]. The transgene was designed to be under the control of a
receptor expressed in a specific cell type, resulting in expression of affinity-tagged
translating ribosomes in that cell population. After dissection and homogenization of
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hippocampal tissue, affinity purification of the ribosomes and their mRNA can be
achieved using anti-GFP antibody-coated beads.

In an additional study, the TRAP

method was expanded to profile 24 different CNS cell populations[11].
An alternative technique involves manual sorting of reporter-labelled cells in
dissociated cell culture[7]. By dissecting slices from the forebrains of transgenic mouse
lines expressing fluorescent proteins in subsets of neurons, the authors suspended the
cells in solution and successfully isolated fluorescent neurons under a dissecting
microscope. The purified sample was then lysed to attain RNA for analysis.
Laser capture microdissection is a procedure that can be used for isolating RNA
from a single cell[8]. In this technique, a transparent thermoplastic film is applied to tissue
or cell cultures on a glass slide. Then, a laser pulse is applied, melting the film to
“capture” the cell(s) of interest, which can then be lysed and examined.
Recently, atomic force microscopy (AFM) nanoprobes have been employed to
extract RNA from single cells[9]. The single cell nanoprobe is inserted into the cell of
interest to extract the cellular ingredients. Unfortunately, limited access to an atomic
force microscope has prevented this technique from gaining wide-spread use at this point.
Finally, the most commonly used approach is RNA isolation via patch pipette,
which was developed by the Eberwine lab[10].

A patch pipette penetrates the cell

membrane to microinject reverse transcriptase and an oligo(dT) primer with a T7 RNA
polymerase promoter site into a single, live cultured primary hippocampal neuron[10a].
The oligo(dT) primer is used to prime the poly(A)+ mRNA for cDNA synthesis by
reverse transcriptase. Then, the cellular contents are aspirated from the cell into the patch
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pipette for the cDNA to be amplified using T7 RNA polymerase to transcribe RNA
copies.
Unfortunately, each of these techniques has disadvantages. FACS and manual
sorting can isolate single cells, but they are limited in that they do not provide any insight
into the location of the cell in tissue. LCM, the AFM nanoprobe method, and TRAP
often suffer from RNA contamination from nearby cells, and TRAP only collects RNA
that is associated with ribosomes. The only approaches that can achieve single cell RNA
isolation while still collecting information about the cellular physiological properties are
LCM, AFM nanoprobe extraction, and patch-pipette isolation.

However, the small

amount of mRNA that can be absorbed by the AFM probe makes this technique difficult
to use, even when coupled with PCR.

Finally, patch-pipette mediated isolation is

difficult to perform and it mechanically injures the surrounding tissue. These drawbacks
motivate the design of an approach that will isolate mRNA from single cells in vivo.
c. Caged compounds for studying the central nervous system
As discussed in chapter one, there are a number of advantages to utilizing light in
biochemical studies.

Since photochemical processes are well-understood, light is

orthogonal to biological processes, and both UV and visible light are minimally invasive,
these compounds can be ideal for studying biological systems. Furthermore, the high
degree of spatiotemporal control these compounds afford can allow for time-resolved
studies and for spatial resolution to study dendrites, synapses, and individual nuclei.
These advantages have led other groups to apply light-activatable compounds to
the study of the central nervous system (CNS). For example, Lima et al. microinjected
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DMNPE-caged ATP into the CNS of Drosophila to study the role of dopaminergic
neurons in the control of movement; a pulse of laser light photoreleased the ATP which
was then free to act as an agonist for an ion channel expressed in a set of neurons[12].
Another approach to photocontrolling a neuronal ion channel was developed by the
Kramer lab[13]. Their caged compound is comprised of a maleimide functional group (for
cysteine tethering to the ion channel) and a quaternary ammonium group linked via a
photoisomerizable azobenzene moiety. In the trans form, the ammonium group can
block the channel, but UV irradiation converts azobenzene to its cis form, rendering the
compound too short to block the channel. In other work, a caged AMPA (α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonist was developed to
monitor surface-exposed AMPA receptors in individual Xenopus oocytes[14] and in single
cells in rat hippocampal cell cultures[15].
d. Hairpin-bandage hybrid design strategy
Considering the many advantages of caged oligonucleotides and the success in
utilizing light-activatable moieties to probe the CNS, we sought to design hairpinbandage hybrids to isolate mRNA from single neurons, a technique we have coined
Transcriptome In Vivo Analysis (TIVA).

Since the caged hairpin-bandage hybrids

discussed in the remainder of this chapter are being used for TIVA, they will be referred
to as “TIVA-tags” for the rest of this chapter.
In designing TIVA-tags to isolate mRNA from individual neurons, we first chose
to utilize a probe strand that could target the poly(A)+ tails of mRNA (Figure 3.1). Since
messenger RNAs (mRNAs) have 3′-polyadenine tails that aid in translation, we designed
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an antisense strand consisting of uracils that can hybridize to this region of mRNA. In
previous work, the Eberwine lab developed a technique that employs peptide nucleic
acids (PNAs) to isolate RNA strands associated with RNA-binding proteins[16]. The PNA
hybridizes to RNA and then photo-crosslinks to the associated proteins. Instead of using
an antisense strand comprised of PNA, we chose a well-characterized, commercially
available RNA analog with increased thermal stability, 2′-fluoro RNA. Substitution of a
fluoro group at the 2′-position locks the ribose ring into the 3′-endo conformation, which
causes duplexes of the RNA to favor A-form helices and increases the melting
temperature of the duplex 2 °C per base relative to DNA[17].
To develop a hairpin-bandage hybrid, two photocleavable spacers are
incorporated to join the probe strand to two blocking strands (Figure 3.1). Both blocking
strands are comprised of 2′-OMe RNA, which also increases the thermal stability and
nuclease resistance of the duplex. Additionally a 3′-biotin tag and a 5′-thiol were added
to the oligonucleotide. Cy3 and Cy5 fluorophores were included to monitor dissociation
of the oligonucleotide after photolysis. These dyes are ideal because they do not absorb
at wavelengths below 400 nm where the photocleavable spacer is activated.
After successfully monitoring oligonucleotide dissociation in vitro, a cellpenetrating peptide (CPP) was conjugated to the oligonucleotide via a disulfide linkage in
order to transport the oligonucleotide into cells. Upon entering the cell, the disulfide
bond is reduced, allowing the peptide to dissociate from the hairpin. In vivo FRET
experiments have been performed in primary cultured neurons and mouse hippocampal
slices. Additionally, mRNA has been isolated from single neurons utilizing the TIVA-
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tag; by lysing the cells and adding magnetic streptavidin beads, it is possible to isolate the
antisense strand bound to mRNA. This allows the mRNA to be eluted by heating and
amplified by the inverse transcription method developed by the Eberwine lab[18].
The studies presented in this chapter detail the in vitro characterization of TIVAtags and their in vivo application to isolate mRNA from single neurons both in primary
culture and in mouse hippocampal slices. Future, more extensive, biological analyses
will allow for gene expression in single cells to be quantified, providing insight into how
mRNA abundances vary temporally as well as spatially (e.g. in dendrites versus
synapses).
II. Experimental procedures
a. Oligonucleotide synthesis and purification
Oligonucleotides were synthesized by standard phosphoramidite chemistry using
an ABI DNA/RNA 394 nucleic acid synthesis system on 1.0 µmole or 10.0 µmole scales.
Reagents obtained from Glen Research included 2′-Fluoro U (10-3430), 2′-OMe A (103100), 5′-thiol C6 spacer (10-1936), Cy3 (10-5913), Cy5 (10-5915), and photocleavable
spacer (10-4913) phosphoramidites, and a 3′-biotin TEG CPG (20-2955). Coupling times
were adjusted to manufacturer’s recommendations, and 0.02 M iodine was used for
oxidation steps.
After cleavage and deprotection using ammonium hydroxide at room temperature
for 24 hours, oligonucleotides were purified on an Agilent 1100S reverse-phase HPLC
(C18 column) with eluents of 0.05 M triethylammonium acetate (A) and acetonitrile (B);
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gradient, 0-40 minutes, 10-60% B, then 60-80% B in 40-50 minutes in A+B; flow rate, 1
mL/min; 40 °C. The retention time of the purified TIVA-tags with 5′-thiol modification
was ~ 50 minutes. Removal of the 4,4′-dimethoxytrityl group was performed by treating
the purified oligonucleotides with 80% acetic acid for 20 minutes at room temperature.
The TIVA-tag was desalted on a Nap-5 column (GE Healthcare) and dried under
vacuum.
b. Conjugation of TIVA-tags to cell-penetrating peptides
The method of conjugating oligonucleotides to CPPs through disulfide bonds was
modified from Turner et al[19].

Briefly, 5 nmol of oligonucleotide with 5′-thiol

modification was deprotected using 50 mM TCEP for two hours.

The TCEP was

removed by desalting on a NAP-5 column (GE Healthcare), and the oligonucleotide was
dried under vacuum. After drying, the oligonucleotide was redissolved in 50 µL of 0.33
M TEAA, 150 µL of formamide was added, and the sample was vortexed. Two CPPs,
(D-Arg)9 and Tat (YGRKKRRQRRR-NH2), each with a cysteine activated with a 3-nitro2-pyridinesulfenyl group (Npys) on the C-terminus, were obtained from Anaspec. CPPs
were dissolved at a concentration of 1 mM in water. To the dissolved oligonucleotide, a
four-fold excess of CPP was added, and the reaction was allowed to proceed overnight at
room temperature.
The conjugation product was purified by anion exchange on an Agilent 1100S HPLC
using a 1 mL Resource Q column with a flow rate of 1 mL/min and a gradient of 0-100%
buffer B in 30 minutes (buffer A: 20 mM Tris-HCl (pH 6.8), 50% formamide; buffer B:
20 mM Tris-HCl (pH 6.8), 50% formamide, 400 mM NaClO4). Finally, the product was
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desalted on a NAP-5 column, dried under vacuum, and characterized by MALDI-TOF
mass spectrometry at the Wistar Institute Proteomics Facility.
c. Mass analysis of TIVA-tags
Matrix-assisted laser desorption/ionization (MALDI) of TIVA-tags was
performed at the Wistar Institute Proteomics Facility at the University of Pennsylvania.
Mass spectra were recorded on an Applied Biosystems Voyager System 6030 MALDITOF mass spectrometer operated in negative mode with 3-hydroxypicolinic acid matrix.
In addition to peaks that correspond to full-length products, peaks consistent with masses
of fragments from photocleavage reactions are present in the MALDI spectra. This is
due to UV pulse laser irradiation required for MALDI-TOF and has been observed
previously when characterizing light-activatable oligonucleotides[20].
d. Melting point determinations
Melting point studies were conducted on a Beckman Coulter DU800 UV-Vis
spectrophotometer equipped with a programmable Peltier temperature controller.
Samples were monitored at 260 nm while heating or cooling at a rate of 1.0 °C/min, with
a one minute hold per degree Celsius. Melting temperatures were determined from the
peak of the first derivative plot of Abs260 vs. temperature.
TIVA-tags were prepared at 1 µM concentration in 10 mM Tris pH 7.5 with 300
mM NaCl and 10 mM MgCl2. To ensure the oligonucleotides were properly annealed,
the samples were heated to 90 °C in a water bath for five minutes, then slowly cooled to
room temperature over approximately three hours. For samples that were photolyzed,
irradiation was carried out using a UV transilluminator (Spectronics Corporation TL-
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365R) at wavelengths centered on 365 nm (9 mW/cm2 at peak intensity) for 15 minutes
with the samples in open 200 µL microcentrifuge tubes.
e. FRET analysis of Cy3/Cy5 labeled TIVA-tags
TIVA-tags with Cy3/Cy5 FRET fluorophores and TIVA-tags with only Cy3 or
only Cy5 were prepared at 1 µM concentration in the same buffer as for the melting point
determination experiments, and photolysis was carried out as discussed above. The
samples were pre-hybridized, and measurements were made in a sub-micro cuvette that
was incubated at 37 °C during emission collection. The fluorescence emissions of Cy3 at
565 nm and Cy5 at 667 nm, upon excitation at 552 nm, were monitored by a Varian
Eclipse fluorimeter (scanning rate of 120 nm/min, and averaging time of 0.5000 sec).
f. Polyacrylamide gel electrophoresis analysis of TIVA-tags
Caged and uncaged TIVA-tag samples (200 pmol in 5 µL water and 5 µ L
formamide) were loaded onto 20 % polyacrylamide, 7 M urea gel.

The following

irradiation conditions were tested: 405 nm laser for 100 µsec per pixel for an image of
512 x 512 pixels; UV laser (351 nm and 364 nm laser lines) for 100 msec, 5 sec, or 10
sec; and UV transilluminator for 15 minutes. Gels were electrophoresed at 300V for 45
minutes, and staining was performed with ethidium bromide for ten minutes. Gels were
imaged on a Bio-Rad Gel Doc 2000 system or a GE Typhoon imaging system.
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III. Results and discussion
a. TIVA-tag characterization
In a preliminary experiment, an 18mer 2′-F strand of all uracils with a biotin tag
was capable of isolating RNA in pull-down assays (unpublished data, Eberwine lab). To
choose an initial blocking strand length, the melting temperature of an 18mer 2′-F RNA
strand of all uracils against different strand lengths of all adenines found the melting
temperature of the poly(U) strand against a 7mer 2′-OMe strand of adenines to be
approximately 24 °C, which is much lower than the temperature used in cell experiments
(Julia Richards, 2010, Development of photoactivatable oligonucleotides, Doctoral
dissertation). Therefore, the first TIVA-tag without dyes was synthesized with an 18mer
uracil antisense strand and two 7mer blocking strands (Figure 3.2A), and it was
characterized by MALDI mass spectrometry at the Wistar Proteomics Facility (Table
3.1).

Thermal denaturation experiments demonstrated that the TIVA-tag has a pre-

photolysis melting temperature of 53.9 °C and a post-photolysis melting temperature of
30.2 °C (Table 3.2, Figure 3.3A). However, the post-photolysis melting temperature is
difficult to assign since the curve is not sigmoidal in shape. This was also the case with
the 18mer 2′-F RNA strand of all uracils against the 7mer 2′-OMe strand of adenines
tested by Dr. Richards (Julia Richards, 2010, Development of photoactivatable
oligonucleotides, Doctoral dissertation). Since the same experiment performed with a
9mer 2′-OMe strand instead of a 7mer resulted in a sigmoidal shaped curve and a melting
temperature of 31 °C, we determined that the post-photolysis melting temperature of the
TIVA-tag is too low to measure accurately. This is because the spectrophotometer’s
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Peltier temperature controller could not cool samples below 15 °C. The short lengths of
oligonucleotides produced after photocleavage should have low melting temperatures,
making it difficult to measure them using this apparatus. While this limitation should be
noted, we are actually most interested in the pre-photolysis melting temperature since all
of the post-photolysis melting temperatures are lower than the 37 °C required for cellular
experiments.
Since there did seem to be a large change in melting temperature (∆Tm) for the
TIVA-tag without dyes, a fluorescently-labeled version of the TIVA-tag (with Cy3 and
Cy5 dyes) was synthesized. This TIVA-tag also had a seemingly large ∆Tm with a
calculated melting temperature of 59.0 °C before photolysis and 29.0 °C after uncaging
(Table 3.2, Figure 3.3B), but the post-photolysis melting curve was also not sigmoidal in
shape. However, since we were confident that the post-photolysis melting temperature is
below 37 °C, we chose to fully characterize the dye-labeled TIVA-tag.
While testing the original fluorescently-labeled TIVA-tag, we also synthesized
and characterized (Figure 3.2, Table 3.1) TIVA-tags with various lengths of antisense and
blocking strands to see if we could generate larger pre-photolysis melting temperatures
since some of our lab’s previously designed hairpins had melting temperatures of
approximately 70 °C. We also introduced a C6 spacer between the 2′-F antisense strand
and the first photocleavable linker to see if the increased flexibility in the loop of the
hairpin would result in a change in melting temperature, but it had little effect (<1 °C) on
the melting temperature (Table 3.2, Figure 3.4A). For the original 18mer antisense
strand, the pre-photolysis melting temperature increases ~7 °C if the blocking strand
lengths are increased to eight adenines each (Table 3.2, Figure 3.4B). On the other hand,
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decreasing the length of the blocking strands or using two blocking strands of different
lengths resulted in a decrease in melting temperature before photolysis (Table 3.2, Figure
3.4C-3.4F).
TIVA-tags with longer antisense strand lengths were also synthesized. When a
TIVA-tag with a 20mer antisense strand and two 7mer blocking strands was examined, it
was found to have a lower pre-photolysis melting temperature than the original TIVA-tag
(Table 3.2, Figure 3.4G). Increasing the number of uracils to 20 or 22 increased the prephotolysis melting temperature when 9mer blocking strands were used (Table 3.2, Figure
3.4H-3.4I). Both of these uncaged constructs had a melting temperature of ~65 °C.
Finally, we performed thermal denaturation studies on TIVA-tags comprised of
all 2′-F RNA bases or all 2′-OMe RNA bases.

When the original TIVA-tag was

designed, 2′-F RNA phosphoramidites were more expensive to purchase, so 2′-F uracils
were only used to synthesize the antisense strand. We chose to synthesize the blocking
strands with 2′-OMe RNA. Now, however, the analogues are similar in cost, so we
synthesized TIVA-tags to determine if it would be preferable to use one analogue over
the other. Since these TIVA-tags had lower pre-photolysis melting temperatures than the
original TIVA-tag (Table 3.2, Figure 3.4J-3.4K), we determined that it is not preferable
to use one only one analogue.
b. In vitro FRET monitoring of TIVA-tag dissociation
To monitor the dissociation of the Cy3/Cy5-labeled TIVA-tag after photolysis, we
measured the fluorescence spectrum and calculated the FRET efficiency (Figure 3.5A).
The FRET efficiency was defined as: Ia / ((γ*Id)+Ia), where Ia is the intensity of the

96

acceptor (Cy5) fluorescence, Id is the intensity of the donor (Cy3) fluorescence, and γ is
the correction factor for the difference in donor and acceptor quantum yields (the
quantum yields for Cy3 and Cy5 are 0.15 and 0.3, respectively). In addition to collecting
the emission spectra for the Cy3/Cy5 TIVA-tag, fluorescence experiments were
performed with a Cy5-only TIVA-tag (Figure 3.5B) and a Cy3-only TIVA-tag (Figure
3.5C) to measure any decrease in fluorescence intensity due to irradiation at 365 nm for
uncaging. By subtracting the Cy5 emission spectrum upon excitation at 552 nm from
that of the Cy3/Cy5 TIVA-tag, any contribution of Cy5 emission by direct excitation,
rather than energy transfer, was eliminated.

To calculate the FRET efficiency, the

average of three independent trials with the Cy5-only TIVA-tag was subtracted from the
average of three trials with the Cy3/Cy5 TIVA-tag, and the corrected emission spectra
were graphed and analyzed (Figure 3.5A). The FRET efficiency was found to be 0.8307
before photolysis and 0.08851 afterwards. This is a 74 % change in FRET efficiency,
indicating a conformational change in the TIVA-tag, i.e. a lysis of the oligonucleotide
into separate parts. Emission spectra of both the Cy3/Cy5 TIVA-tag and the Cy5-only
TIVA-tag excited at 643 nm were also collected to monitor the direct excitation of Cy5
dye in each case (Figure 3.5D-3.5E).
c. Gel analysis of TIVA-tag uncaging
We also verified oligonucleotide dissociation post-photolysis by denaturing
polyacrylamide gel electrophoresis (PAGE) (Figure 3.6A). TIVA-tags before or after
photolysis were loaded in a 20% PAGE, 7M urea gel, which was electrophoresed at 300V
for 45 minutes.

Staining with ethidium bromide for ten minutes revealed bands

corresponding to intact TIVA-tag and photolysis products. Only one band was present
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for the caged TIVA-tag sample. Samples irradiated with a 405 nm laser or for five or ten
seconds with a UV laser displayed two photolysis bands that ran faster on the gel than the
caged oligonucleotide, but there was also some caged TIVA-tag present. Irradiation for
100 msec with the UV laser uncaged very little TIVA-tag. Finally, irradiating for 15
minutes with a UV transilluminator completely uncaged the TIVA-tag, as can be
determined by the presence of only two photolysis product bands on the gel. The two
photolysis products seen on the gel correspond to the 3′ end of the TIVA-tag with either
one photocleavable group (the highest photolysis band) or two photocleavable groups
(the lowest photolysis band) cleaved.

This was confirmed by a denaturing

polyacrylamide gel imaged with a GE Typhoon Imager using the fluorescence setting
(Figure 3.6B).

In this gel, both photolysis products fluoresce green, indicating the

presence of the Cy3 dye. The band for the uncaged TIVA-tag appears yellow due to the
overlap of the Cy3 and Cy5 (shown in red) dyes (Figure 3.6B).
d. Preparation of TIVA-tags for cellular experiments
To facilitate the cellular uptake of TIVA-tags we conjugated them to cellpenetrating peptides (CPPs). Preliminary experiments performed by Dr. Ditte Lovatt in
the

Eberwine

lab

discovered

that

fluorescently-labeled

(specifically

carboxytetramethylrhodamine-labeled) Tat and (D-Arg)9 CPPs at a concentration of 10
µM efficiently transduced the dye into cortical cultured neurons (Unpublished results,
Eberwine lab). Therefore, we chose to conjugate TIVA-tags to these CPPs via disulfide
bonds following a protocol modified from work done by Turner et al[19].
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Following the conjugation reaction, TIVA-tag conjugates were purified by anion
exchange chromatography using highly denaturing conditions (50% formamide) in order
to prevent excess cationic CPP from remaining bound to the negatively charged
oligonucleotide and to prevent precipitation. Typical HPLC chromatograms show that
compared to the reduced oligonucleotide alone (Figure 3.7A), both the (D-Arg)9 conjugated TIVA-tag (Figure 3.7B) and the Tat-conjugated TIVA-tag (Figure 3.7C)
eluted a couple of minutes earlier at approximately 22 minutes.

These results are

consistent with the earlier elution time for conjugates observed by Turner et al. for their
CPP-oligonucleotide conjugates[19].

After desalting and drying the conjugates under

vacuum, they could be redissolved in water, that their masses were confirmed by
MALDI-TOF mass spectrometry. The masses of (D-Arg)9-TIVA-tag and Tat-TIVA-tag
were found to be 14,430.31 and 14,432.46, respectively (compared to expected masses of
14,412.7 and 14,547.8, respectively) (Figure 3.8).
e. In vivo studies
Our collaboration with the Eberwine lab has enabled us to test TIVA-tags in
dispersed primary neuron cell culture and acute mouse hippocampal slices. The initial
aim was to monitor the change in FRET in cultured neurons. By incubating cultured
cortical neurons (prepared for 7-12 days in vitro), with 10 µM (D-Arg)9-TIVA-tag for ten
minutes, a decrease in Cy5 intensity and increase in Cy3 intensity in a single neuron was
observed after irradiation with a 405 nm laser (Figure 3.9, in collaboration with Dr. Ditte
Lovatt).
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Next, we moved on to investigate whether TIVA-tag dissociation could be
monitored in hippocampal tissue. While cultured neurons are very useful for single cell
studies, there are significant differences between cultured cells and intact tissues. For
instance, cultured cells are grown on 2-D plates, so they lack the inherent 3-D
morphology of tissue. Additionally, cellular organization and neuronal connections are
maintained in tissue but not cultured cells. Due to these inherent differences and the fact
that live tissue slices are more similar to the intact brain, it would be highly beneficial to
be able to isolate mRNA from single neurons in live tissue. Therefore, we incubated live
hippocampal slices from a 60-day old mouse for 40 minutes with 10 µM (D-Arg)9-TIVAtag. After uncaging the TIVA-tag with a 405 nm laser, there is a significant increase in
Cy3 fluorescence and a decrease in Cy5 fluorescence intensity, indicating dissociation of
the TIVA-tag (Figure 3.10, in collaboration with Dr. Jai-Yoon Sul).
In addition to monitoring TIVA-tag photolysis in vivo, mRNA has been isolated
successfully from a single neuron from a live slice. After incubating a slice from a 60day old mouse with TIVA-tag and uncaging the TIVA-tag in a single neuron, the cells
were lysed, and magnetic streptavidin beads were added to pull-down the antisense strand
still bound to mRNA. Next, the oligonucleotides were heated to greater than 50 °C to
elute the mRNA since the melting temperature of an 18mer 2′-F uracil oligonucleotide
tagged with Cy3 and 3′-biotin against an 18mer poly(A)+ RNA strand was found to be 50
°C (Figure 3.11). Finally, the RNA was amplified using the antisense RNA amplification
procedure[10], the RNA was cleaved into smaller fragments, and the material was loaded
onto a nanochip gel and electrophoresed in a nanochip bioanalyzer. As shown in Figure
3.12, the uncaged TIVA-tag was successful in isolating mRNA from a single neuron, and
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there was minimal RNA background from an uncaged neuron (Figure 3.12, in
collaboration with Dr. Peter Buckley). Ongoing sequencing analysis of the isolated RNA
will enable us to qualitatively compare what RNA sequences the TIVA-tag is isolating,
but preliminary results indicate that the TIVA-tags are pulling down RNA comparable to
the patch pipette method and that the isolated RNA population is not rich in poly(A)+
sequences. However, the real strength of the TIVA-tag is that it is capable of isolating
RNA from live tissue, which is a limitation of current RNA isolation approaches.
IV. Conclusions
The goal of combining the photoactivatable hairpins and bandages previously
developed by our lab was to develop a hairpin with a longer blocking strand but that
retains a low melting temperature after photolysis. Thus far, this approach has been
successful in the case of our original TIVA-tag. In addition to the large change in
melting temperature, the first generation TIVA-tag has been used successfully in vivo. In
our studies with cultured neurons and live hippocampal slices, there appears to be
minimal background prior to photolysis, suggesting that the TIVA-tag is stable in cells.
To investigate whether the basic TIVA-tag design could be improved upon,
particularly as other biological uses are developed, we synthesized and characterized
TIVA-tags with various lengths of antisense and blocking strands.

Since the first

generation TIVA-tag has a lower pre-photolysis melting temperature (60 °C) compared to
our lab’s successful caged hairpins (~70 °C), it is possible that the TIVA-tag design may
need to be optimized, focusing on increasing its stability before uncaging to ensure that
no RNA is collected before photolysis.

Upon investigating other designs, it was
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determined that new TIVA-tags with the largest pre-photolysis melting temperatures are
the 18mer antisense strand with 8mer blocking strands and the 20mer probe with 9mer
blocking strands.
Also, we have started to consider more extensive modifications that can be made
in the development of second generation TIVA-tags. These include introducing new
targeting moieties for optimizing specificity for particular cell types or cellular locations,
changing to caging moieties like those with two-photon capabilities to optimize
spatiotemporal control, and attempting to increase the thermal stability of the TIVA-tag
by adding G-C residues to the 3′or 5′-end of the poly(U)/poly(A)+ strands.
Thus far, work has only begun on considering other methods for targeted delivery
of TIVA-tags. An obvious possibility for new targeting moieties, due to the increased
commercial availability of CPPs, would be to conjugate other CPPs to the TIVA-tag to
target specific cell types. Another option we have started to explore is folate receptor
delivery.

Folate receptors are highly selective tumor markers that are commonly

overexpressed in cancer cells, particularly ovarian cancer cells[21]. Folate receptors have
a high-affinity for folic acid, which has been utilized as a receptor mediated delivery
agent for cargo, such as antibodies[21], contrast agents[21], and oligonucleotides

[22]

. This

is because folate is able to retain its receptor binding properties when conjugated to a
biomolecule via its γ–carboxyl. Therefore, we synthesized a folate-conjugated TIVA-tag
(Figure 3.13), which may open the door for utilizing TIVA-tags to study mRNA
specifically from cancer cells, if its in vivo use can be optimized.
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Another obvious extension is to apply the hairpin-bandage hybrid approach to
traditional antisense applications. One such possibility is to inhibit microRNA activity.
microRNAs (miRNAs) are short, double stranded RNA molecules comprised of 21-23
nucleotides with two nucleotide 3′overhangs which regulate gene expression. Let-7 was
the first known miRNA; it was discovered in C. elegans and is evolutionarily conserved.
It is an interesting target because it has been shown to target several known oncogenes,
making it an interesting subject for cancer research[23]. Preliminary work in our group
has focused on photomodulating let-7 miRNA activity using the hairpin-bandage hybrid
design. To this end, we have caged a 2′-OMe strand that is antisense to the let-7 miRNA
sequence using two photocleavable groups to divide the blocking strand into two parts
(Figure 3.14). A FRET pair was also incorporated in order to monitor dissociation. The
field of photoregulating microRNA has only recently been explored. The Li lab has
developed an oligonucleotide design similar to our caged hairpins where they have a 2′OMe RNA antisense strand that blocks a miRNA of interest linked to a blocking strand
via a bifunctional caged linker[24]. Since their antisense strand was not fully blocked, a
small amount of background activity was observed before photolysis. If the change in
melting temperature for the caged miRNA inhibitor can be optimized, the hybrid design
should be a better approach because there should not be any background activity due to
complete blockage of the antisense strand.

Future work in our lab will include

characterizing and testing this caged miRNA in zebrafish embryos.
In conclusion, we have developed a new method for utilizing two photocleavable
linkers to lower the melting temperature of oligonucleotides after photolysis. We have
also monitored oligonucleotide dissociation, both in vitro and in vivo, using a FRET pair.
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Finally, we have successfully employed the first generation of TIVA-tags to pull-down
mRNA from single neurons. Future work will focus on further developing the next
generation TIVA-tags in addition to creating other hairpin-bandage hybrids for a variety
of applications.
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Figure 3.1 Schematic representation of TIVA-tag before and after photolysis. A 2′-F
RNA strand (blue) is caged via a photocleavable linker (red) to two shorter
complementary 2′-OMe RNA strands (green) which are joined by a second
photocleavable linker (red). The 2′-F RNA strand is labeled with a biotin moiety, and a
cell-penetrating peptide (CPP) is connected to the 5′-end of the 2′-OMe RNA strand by a
disulfide bond. After photolysis, the 2′-OMe RNA strand breaks into two shorter
oligonucleotides, which then dissociate from the 2′-F RNA. Dissociation can be
monitored by means of the Cy3 (pink) and Cy5 (purple) dyes on the 2′-F RNA and 2′OMe RNA strands, respectively. Finally, the 2′-F RNA can hybridize to the poly(A)+ tail
of mRNA (gray) in the cell.
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Figure 3.2 Structures of TIVA-tags: A) General structure of TIVA-tags with various
probe and blocking strand lengths, B) TIVA-tag with Cy3/Cy5 dyes, which was utilized
for in vitro and in vivo experiments.

A)

B)
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Table 3.1 Table of TIVA-tags and masses determined by MALDI-TOF mass
spectrometry.
TIVA-tag
TIVA (no dyes)
Cy-TIVA
Arg-Cy-TIVA
Tat-Cy-TIVA
Folate-Cy-TIVA
Cy5-TIVA
Arg-Cy5-TIVA
All 2'-F TIVA
All 2'-OMe TIVA
18U/6A/6A TIVA
18U/8A/8A TIVA
20U/7A/7A TIVA
20U/9A/9A TIVA
22U/9A/9A TIVA
18U/7A/5A TIVA
18U/5A/7A TIVA
18U/7A/9A TIVA
C6 Spacer TIVA

Expected Mass
(g/mol)
11,862.7
13,019.9
14,412.7
14,547.8
13,165.7
12,499.9
13,892.7
11,708.2
12,093.4
11,058.2
12,431.2
12,493.0
13,733.0
14,482.3
11,190.2
11,190.2
12,563.2
12,152.8

Measured Mass
(g/mol)
11,851.49
13,047.06
14,430.31
14,432.46
13,209.02
12,604.22
13,952.62
11,673.49
12,086.65
11,134.18
12,489.78
12,602.78
13,800.85
14,487.06
11,218.53
11,211.94
12,569.06
12,178.03
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Table 3.2 Melting temperatures of TIVA-tags. Oligonucleotide concentration of 1 µM
in 10 mM Tris pH 7.5 buffer with 300 mM NaCl and 10 mM MgCl2 was used for all
experiments.
TIVA-tag
TIVA (no dyes)
Cy-TIVA
Arg-Cy-TIVA
Tat-Cy-TIVA
Folate-Cy-TIVA
Cy3-TIVA
Cy5-TIVA
All 2'-F TIVA
All 2'-OMe TIVA
18U/6A/6A TIVA
18U/8A/8A TIVA
20U/7A/7A TIVA
20U/9A/9A TIVA
22U/9A/9A TIVA
18U/7A/5A TIVA
18U/5A/7A TIVA
18U/7A/9A TIVA
C6 Spacer TIVA

Pre-photolysis Melting
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Thermal denaturation curves for TIVA-tags after photolysis were not sigmoidal in shape.
Therefore, it was not possible to assign melting temperatures to the TIVA-tags after
photolysis. This is likely due to the fact that the Peltier temperature controller was unable
to cool the samples to temperatures lower than 15 °C, and the short oligonucleotides
produced after photolysis should have melting temperatures of less than 30 °C.
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Figure 3.3 Thermal denaturation curves for TIVA-tag A) without dyes, B) with
Cy3/Cy5 dyes, and C) with only Cy3 or only Cy5 dyes before and after photolysis at 365
nm. TIVA-tags were hybridized in standard buffer, and melting temperatures were
determined from the peak of the first derivative plot of Abs260 versus temperature. The
melting temperature for the TIVA-tag without dyes were found to be 53.9 °C prephotolysis. For the TIVA-tag with dyes, the before photolysis melting temperature was
59.0 °C.
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Figure 3.4 Thermal denaturation curves of TIVA-tags with A) C6 spacer, B-I) various
sense and antisense strand lengths, J) all 2′-F residues, and K) all 2′-OMe residues before
and after photolysis at 365 nm. TIVA-tags were hybridized in standard buffer, and
melting temperatures were determined from the peak of the first derivative plot of Abs260
versus temperature.
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Figure 3.5 Emission spectra of TIVA-tags before and after photocleavage. TIVA-tags
were prepared in standard buffer and hybridized prior to FRET analysis. Fluorescence
emission spectra were collected at 37 °C. A) The emission spectra of the Cy5-only
TIVA-tag upon excitation at 552 nm were subtracted from the original wavelength scans
of the Cy3/Cy5 TIVA-tag also excited at 552 nm to correct for any direct excitation of
Cy5 dye (not due to energy transfer). The FRET efficiency was found to be 83.1 %
before photolysis and 8.9 % post-photolysis, which is a 9.4-fold decrease in FRET
efficiency. B) Emission spectra of Cy5-only TIVA-tag upon excitation at 552 nm. C)
Emission spectra of Cy3-only TIVA-tag upon excitation at 552 nm. D) Emission spectra
of Cy3/Cy5 TIVA-tag excited at 643 nm. E) Emission spectra of Cy5-only TIVA-tag
excited at 643 nm. Each spectrum (full lines) is the average of three independent trials,
and each graph also includes a spectrum of the minimum (dotted lines) and maximum
values (dashed lines) of the three trials.
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Figure 3.6 Denaturing PAGE (20%) analysis of TIVA-tags before and after uncaging.
A) 200 pmol of oligonucleotide were loaded per well, gel was electrophoresed at 300 V
for 45 minutes, and staining was performed with ethidium bromide for ten minutes. (1)
Non-irradiated TIVA-tag; (2) TIVA-tag + irradiation with 405 nm laser; (3) TIVA-tag +
100 msec irradiation with UV laser; (4) TIVA-tag + 5 sec irradiation with UV laser; (5)
TIVA-tag + 10 sec irradiation with UV laser; (6) TIVA-tag + 15 min irradiation with UV
transilluminator. B) 200 pmol of oligonucleotide were loaded per well, gel was
electrophoresed at 300 V for 45 minutes, and gel was imaged with a GE Typhoon Imager
using the fluorescence setting. (1) Non-irradiated TIVA-tag; (2) TIVA-tag + irradiation
with 405 nm laser. Green indicates Cy3 dye, and red represents Cy5 dye.
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Figure 3.7 Representative HPLC traces showing purification of Cy3/Cy5 TIVA-tag
TIVA
conjugation reaction to CPPs
CPPs. A) TIVA-tag deprotected with TCEP has a retention time
of ~24 minutes. B) TIVA
TIVA-tag conjugated to (D-Arg)9 has ~22 minute
ute retention time. C)
TIVA-tag conjugated to Tat has retention time of ~
~22 minutes.. Absorbances
Absorbance at 552 nm
and 643 nm are shown (rather than oligonucleotide absorbance at 254 nm) due to the
inherent absorbance of formamide (which is present in the running buffer) at 254 nm.
A)

B)
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Figure 3.8 MALDI-TOF analysis of CPP-conjugated TIVA-tags. A) Mass spectrum of
(D-Arg)9-TIVA-tag. The peak at 14,430.31 corresponds to the intact (D-Arg)9-TIVA-tag
(expected mass is 14,412.7). B) Mass spectrum of Tat-TIVA-tag. The peak at
14,432.46 corresponds to the intact Tat-TIVA-tag (expected mass is 14,547.8). In both
spectra, lower mass peaks are indicative of photolysis products resulting from
oligonucleotide cleavage due to MALDI laser exposure.
A)
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Figure 3.9 Uncaging of TIVA-tag in the body of a single cultured neuron. Cultured
cortical neurons (7-12 days in vitro) were incubated with 10 µM (D-Arg)9-TIVA-tag.
Irradiation was performed at 405 nm to uncage the oligonucleotide. Emission from 532
nm to 707 nm was collected after excitation at 514 nm.
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Figure 3.10 Activation of TIVA-tag in a single dendrite and an individual cell soma in
the live brain slice preparation from a 60-day old mouse. Slices were incubated with 10
µM (D-Arg)9-TIVA-tag. The arrow points to the dendrite in which the TIVA-tag was
uncaged with 405 nm light. The inset shows a single cell soma in which TIVA-tag is
irradiated at 405 nm. Both the dendrite and the cell soma were excited at 514 nm, and
emission from 532 nm to 707 nm was collected. Cy5 fluorescence is indicated by red,
and Cy3 fluorescence is shown in green.
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Figure 3.11 Thermal denaturation curve of an 18mer 2′F-U strand with Cy3 dye and
biotin at the 3′-end hybridized to 18mer poly(A)+ RNA strand. Oligonucleotides were
hybridized in standard buffer, and melting temperatures were determined from the peak
of the first derivative plot of Abs260 versus temperature. The melting temperature was
found to be 50.2 °C.
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Figure 3.12 Representative nanochip analysis of mRNA isolated from a single neuron.
After TIVA-tag isolation from a single neuron in the live slice preparation, the mRNA
was amplified using the antisense RNA amplification procedure. Then, the RNA samples
were then cleaved into smaller fragments and loaded on a nanochip gel and
electrophoresed in a bioanalyzer. The left lane is the RNA ladder. The sample in the
caged lane was isolated from a cell that was not irradiated, so it serves as the control.
The uncaged sample represents RNA isolated from a single neuron.
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Figure 3.13 Structure of folate-conjugated TIVA-tag with Cy3 and Cy5 dyes.
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Figure 3.14 Structure of hairpin-bandage hybrid targeting let-7 microRNA.
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Appendix
Supplemental information for caging siRNA
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I. Design strategy
As discussed in chapter one, there is a demand for the development of lightactivatable approaches for controlling gene expression, and many recent advances have
been made in controlling RNA interference (RNAi) with light[1]. This is a desirable
approach because it is not challenging to design siRNA sequences for any gene of
interest, and very small amounts of material are required (on the order of pmol).
Unfortunately, many of the early caged siRNA designs were unable to completely block
siRNA activity prior to irradiation[1c, 1e]. A more recent advance has ameliorated RNAi
inhibition pre-photolysis using a new photocleavable group, cyclo-dodecyl DMNPE (CDDMNPE)

[2]

. Incorporation of this photolabile group at both the 3′ and 5′ ends of the

sense and antisense strands of an siRNA duplex prevents any RNAi prior to irradiation.
However, this caging strategy requires a lengthy synthesis. Therefore, we sought to
design a siRNA duplex that is fully blocked the 3′ and 5′ ends, but that involved a simpler
synthesis strategy.
In our design, a siRNA that incorporates two photoactivatable groups linking a 2′fluoro (2′-F) antisense strand targeting EGFP and a 2′-F/DNA chimera blocking strand
was synthesized entirely by solid-phase synthesis (Figure S1.1) and characterized by
MALDI-TOF (Figure S1.2). Previous studies have demonstrated that 2′-F siRNA has
increased nuclease resistance in vitro and in vivo (compared to unmodified RNA) and is
equally effective at gene suppression[3]. Blidner et al. have demonstrated that a fully 2′fluoronated siRNA can elicit RNAi with similar activity to unmodified RNA when they
photoregulated a siRNA. However, since they were using the DMNPE group, their
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approach also suffered from siRNA activity prior to photolysis. To fully block any
activity from the caged construct, we circularized the duplex by ligation with Circligase
enzyme to fully block the 3′ and 5′ ends (Figure S1.3).
II. Experimental procedures
a. Oligonucleotide synthesis and purification
Oligonucleotides were synthesized by standard phosphoramidite chemistry using
an ABI DNA/RNA 394 nucleic acid synthesis system on a 1.0 µmol scale. Reagents
were obtained from Glen Research, coupling times were adjusted to manufacturer’s
recommendations, and 0.02 M iodine was used for oxidation steps. After cleavage and
deprotection with ammonium hydroxide at room temperature for 24 hours,
oligonucleotides were purified on an Agilent 1100S reverse-phase HPLC (C18 column)
with eluents of 0.05 M triethylammonium acetate (A) and acetonitrile (B); gradient 0-40
minutes, 10-60% B in A+B; flow rate, 1 mL/min. The retention time for the purified
product is ~30 minutes. Removal of the 4,4`-dimethoxytrityl group was performed by
treating the purified oligonucleotides with 80% acetic acid for 20 minutes at room
temperature and drying under vacuum.
b. Mass analysis of caged siRNA
Matrix-assisted laser desorption/ionization (MALDI) was performed at the Wistar
Institute Proteomics Facility at the University of Pennsylvania.

Mass spectra were

recorded on an Applied Biosystems Voyager System 6030 MALDI-TOF mass
spectrometer operated in negative mode with 3-hydroxypicolinic acid matrix. In addition
to the peak that corresponds to full-length product, peaks consistent with masses of
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fragments from photocleavage reactions are present in the MALDI spectra. This is due to
UV pulse laser irradiation required for MALDI-TOF and has been observed previously
when characterizing light-activatable oligonucleotides[4].
c. Oligonucleotide ligation
Purified oligonucleotides were ligated using Circligase II (Epicentre). Briefly, 40
pmol of oligonucleotide was reacted in a total reaction volume of 20 µL according to
manufacturer’s recommendations. The reaction was performed at 60 °C for one hour.
Then, the enzyme was heat inactivated, and the reaction mixture was treated with
exonucleases I and III (NEB, following manufacturer’s protocols) to cleave any
oligonucleotide that was not circularized. For oligonucleotide purification, the reaction
mixture was extracted with phenol/chloroform and precipitated with sodium acetate.
Finally, the circularized oligonucleotide was applied to an Amicon 10,000 Da molecular
weight cut-off centrifugal filter unit to ensure the full-length oligonucleotide was isolated
from any short, linear nucleotides produced during the exonuclease reaction.
d. Polyacrylamide gel electrophoresis analysis of caged siRNA
Samples (40 pmol of unligated caged siRNA, 40 pmol of caged siRNA after
Circligase reaction, 20 pmol of purified caged siRNA after Circligase and exonuclease
reactions, and 20 pmol of purified product after irradiation at 365 nm for 15 minutes)
were brought to a total volume of 10 µL. Then, 10 µL of loading buffer II (Ambion) was
added to each sample, and they were loaded onto 20% polyacrylamide, 7 M urea gel.
The gel was electrophoresed at 300 V for 45 minutes, and staining was performed with
ethidium bromide for 10 minutes. Gels were imaged on a Bio-Rad Gel Doc 2000 system.
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Samples that were uncaged were irradiated with a UV transilluminator (Spectronics
Corporation TL-365R) at 365 nm (9 mW/cm2 at peak intensity) for 15 minutes.
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Figure S1.1 Caged siRNA structure and general ligation scheme. 2′-F bases are
indicated in blue, DNA bases are black, and photocleavable spacer groups are red.
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Figure S1.2 MALDI-TOF analysis of caged siRNA. The peak at 14,310 corresponds to
the intact caged siRNA (expected mass is 14,136). The lower mass peaks are indicative
of photolysis products resulting from oligonucleotide cleavage due to MALDI laser
exposure.
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Figure S1.3 Denaturing PAGE (20%) analysis confirming formation of circularized
siRNA by ligation. 40 pmol of (1) unligated caged siRNA and (2) caged siRNA after
Circligase reaction were loaded on gel. 20 pmol of (3) purified caged siRNA after
Circligase and exonuclease reactions and (4) purified product after irradiation at 365 nm
for 15 minutes were loaded on the gel. The gel was electrophoresed at 300 V for 45
minutes, and staining was performed with ethidium bromide for 10 minutes.
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